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ABSTRACT 
Carmen Carol Cuthbertson: Associations of physical activity and sedentary behavior with life 
expectancy free of cardiovascular disease and cancer 
(Under the direction of Kelly R. Evenson) 
Engagement in high levels of physical activity have been linked to a lower risk of 
cardiovascular disease (CVD), cancer, and all-cause mortality. Conversely, greater amounts of 
sedentary behavior have been associated with an increased risk of these outcomes. Participation 
in more physical activity compared to less has also been associated with longer disease-free life 
expectancy from composite measures of chronic disease. However, research in this area has not 
included cancer outcomes or examined sedentary behavior.   
This dissertation quantified the associations of physical activity and sedentary behavior 
with life expectancy free of three types of nonfatal CVD (coronary heart disease, stroke, and 
heart failure) and four types of cancer (colorectal, lung, prostate, and postmenopausal breast 
cancer). Analysis was conducted on data from the Atherosclerosis Risk in Communities Study 
(1987 – 2016). We included 13,534 participants in the CVD analyses and 14,508 participants in 
the cancer analyses. Life expectancies were estimated separate for men and women. 
Across all diseases, engagement in LTPA was associated in an inverse dose-response 
fashion with life expectancy free of each disease. Engaging in LTPA less than the median 
compared to no LTPA was associated with 0.8 – 1.3 year greater CVD- and cancer-free life 
expectancy. Engaging in LTPA greater than or equal to the median compared to no LTPA was 
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associated with a longer disease-free life expectancy for coronary heart disease (men-1.5 years, 
women-1.6 years), stroke (men-1.8 years, women-1.8 years), heart failure (men-1.6 years, 
women-1.7 years), colorectal cancer (men-2.2 years, women-2.3 years), lung cancer (men-2.1 
years, women-2.1 years), prostate cancer (1.5 years), and postmenopausal breast cancer (2.4 
years). Viewing TV seldom/never compared to often/very often viewing was associated with 
longer CVD- and cancer-free life expectancy of 0.8 – 1.2 years for men and women and all 
diseases except prostate cancer.  
These findings suggest that engaging in more LTPA and viewing less TV may contribute 
to living more years free of many types of CVD and cancer.  
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CHAPTER 1: INTRODUCTION 
 
Chronic diseases are the leading cause of death, premature mortality, and years lived with 
disability in the United States (US). 1, 2 Although chronic disease mortality rates have declined 
and life expectancy has increased, many adults are living longer in poor health.2 In 2010, the 
average US life expectancy at birth was 78.2 years but adults could expect to live at least 10 
years with illness and disability.2 The major contributors to the chronic disease burden are 
cardiovascular disease (CVD) and cancer. 3 The major CVDs are coronary heart disease (CHD), 
stroke, and heart failure (HF) 4 and the leading cancers are breast, prostate, lung, and colorectal 
cancer. 5  
Two modifiable behaviors linked to these chronic diseases are physical activity and 
sedentary behavior. Consistent epidemiological evidence suggests physical activity reduces the 
risk of CHD, stroke, HF, postmenopausal breast cancer, colorectal cancer, lung cancer, and 
prostate cancer. 6, 7 Sedentary behavior, conversely, is linked to increasing the risk of these 
diseases. 8, 9 Three studies have used health expectancy outcomes, defined as a class of metrics 
that combine morbidity and mortality information, to estimate life expectancy free of CVD by 
level of physical activity. Findings from these studies suggested that participation in greater 
amounts of physical activity compared to lower levels was associated with a longer CVD-free 
life expectancy.10-12 Research in this area has been limited to use of physical activity 
measurements that are challenging to generalize to other populations and to studies without 
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cancer outcomes. In addition, no studies using health expectancy outcomes have included 
sedentary behavior.    
This dissertation examined how physical activity and sedentary behavior were associated 
with CVD and cancer life expectancy outcomes. The first aim evaluated the association of 
leisure-time physical activity with life expectancy free of three CVDs (CHD, stroke, HF) and 
four cancers (postmenopausal breast cancer, colorectal cancer, lung cancer, prostate cancer).  
The second aim evaluated the association of sedentary behavior with the same outcomes. Our 
findings suggested that engaging in more physical activity compared to no physical activity and 
less TV viewing compared to more viewing were associated with living more years free of seven 
leading chronic diseases. Identifying interventions that extend the number of healthy years is a 
priority for improving and maintaining the health of older adults, as this population is expected 
to increase, 13 and the current chronic disease burden suggests many years may be spent 
managing illness and disability.  
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CHAPTER 2: STATEMENT OF SPECIFIC AIMS 
Aim 1: To evaluate the association of physical activity with disease-free life expectancy at 
age 50. 
Hypothesis 1.1: There is a positive dose response relationship between leisure-time moderate-to-
vigorous physical activity (LTPA) with disease-free life expectancy for three CVDs (CHD, 
stroke, HF) and four cancers (colorectal, lung, prostate, breast).  
 
Aim 2: To evaluate the association of sedentary behavior with disease-free life expectancy 
at age 50. 
Hypothesis 2.1: There is an inverse dose response relationship between TV viewing with 
disease-free life expectancy for three CVDs (CHD, stroke, HF) and four cancers (colorectal, 
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CHAPTER 3: BACKGROUND AND REVIEW OF THE LITERATURE 
3.1  Life expectancy and chronic disease 
3.1.1  Population aging and life expectancy 
Populations are aging worldwide and are predicted to continue to increase in average age. 
In 2015, 8.5% (617.1 million) of the worldwide population was 65 or older and this proportion is 
predicted to be 12% (998.7 million) by 2030 and 16.7% (1,565.8 million) by 2050.13  Part of the 
increase in the older adult population is because life expectancy has increased over the past 100 
years.13  
In the United States (US) in 2014, life expectancy at birth was 78.8 years, at age 50 was 
31.6 years, and at age 65 was 19.3 years (Table 1).14 In examining differences by race and 
gender, white females at any age have the longest life expectancy, followed by African American 
females and white males. The lowest life expectancy across all ages is for African American 
males. As displayed in Figure 1, the magnitude of life expectancy differences by race and gender 
has decreased over time, but disparities are still observed. 
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Figure 1. Life expectancy at birth by 
gender and race in the US.  
Figure 1 from 15.  
Table 1. Life expectancy at birth, age 50, 
and age 65 by race and gender in 2014 in 
the US. 
 At birth Age 50 Age 65 
Overall 78.8 31.6 19.3 
White male 76.7 29.9 18.0 
Black   male 72.5 27.1 16.3 
White female 81.4 33.4 20.5 
Black female 78.4 31.5 19.6 
Life expectancy estimates from 14. 
 
 
3.1.2  Burden of chronic disease 
Over the past 100 years mortality due to infectious diseases has declined and mortality 
due to chronic diseases has increased. In the early 1900’s, the top causes of death were 
pneumonia or influenza, tuberculosis, and gastrointestinal infections.16 By 2014, the top causes 
of death were heart disease and cancer, accounting for 45.9% of all deaths across race and gender 
groups.3   
CVD and cancer are not only the leading causes of death, but they also cause a large 
burden of morbidity. The Global Burden of Disease (GBD) project estimates metrics that inform 
on morbidity and mortality due to individual diseases. Some of the metrics the GBD uses include 
years of life lost due to premature mortality (YLL), years lived with disability (YLD), and 
disability-adjusted life years (DALYs). In 2016 in the US, the top three diseases contributing to 
YLL were ischemic heart disease, lung cancer, and chronic obstructive pulmonary disease.17 
Other leading contributors to YLL were colorectal cancer (ranked 5th), stroke (ranked 10th), 
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breast cancer (ranked11th); prostate cancer was not among the leading YLL causes. The only 
CVD or cancer that was a leading cause of YLD was stroke (ranked 15th). DALYs represent a 
health gap between current health status and ideal health. In terms of DALYs, the leading causes 
were ischemic heart disease, lung cancer, and chronic obstructive pulmonary disease. Stroke was 
ranked 12th, colorectal cancer 17th, breast cancer 20st, and prostate cancer was not in the top 25 
leading causes of DALYs.17 In summary, many types of CVD and cancer contribute to premature 
mortality and loss of healthy life years.  
3.1.3  Health expectancy measures  
The increase in life expectancy, accompanied by high rates of chronic disease, suggest 
the years of life gained may not be spent in good health. Therefore, metrics that inform on the 
number of years spent in good and poor health are valuable for monitoring population health. 
Health expectancy measures are a class of metrics that combine morbidity and mortality 
information to reflect the average number of years a person can expect to live in full health. 18-21 
These measures combine quantity and quality of life and can be more informative than life 
expectancy alone. These measures can complement other population health measures (i.e., 
incidence, prevalence) that do not inform on how long a person lives with disease or disability. 
This type of information can illustrate if years of life spent unhealthy are expanding or 
decreasing with the increase in life expectancy. Governments and policymakers can use this 
information to set realistic retirement ages, to plan for pensions, and predict health care and long 
term care needs and costs.22 Health expectancy measures include active life expectancy, 
disability-free life expectancy, healthy life expectancy, disease-specific free life expectancy, and 
healthy adjusted life expectancy (HALE).  
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Health expectancy measures differ in how health is defined (Table 2). 22 For example, 
active life expectancy uses dependency in activities of daily living to define health. Similarly, 
disability-free life expectancy is constructed using functional limitations. Healthy life expectancy 
is often constructed using self-rated health. The GBD metric of HALE is based on over 220 
distinct states of health and disability associated with those states.18 The health expectancy 
outcome used less often is disease specific free life expectancy.  
Of the studies that examined disease specific free life expectancy, outcomes have 
included CVD,10-12, 23, 24 diabetes,25 and chronic disease (combination of many diseases).26-29 A 
recent systematic review on health expectancy measures among older adults identified 90 
studies; 76 of these studies measured health expectancy with either dependency in activities of 
daily living or difficulty in functional limitations and 14 studies used self-rated health.22 
However, studies that examined disease specific free life expectancy (i.e., CVD, diabetes, 
chronic diseases) were not included in this review. 
 
Table 2. Description of different health expectancy measures. 




Number of years a person is expected to live without 
restrictions in activities of daily living  
Disability-free life 
expectancy  
Number of years a person is expected to live free of 
disability often measured by functional limitations 
Healthy life 
expectancy  
Number of years a person is expected to live in full 
health, often measured with self-rated health  
Disease specific free 
life expectancy 
Number of years a person is expected to live without 
specific diseases 
 
Calculations of health expectancy outcomes can inform on average years of life spent in 
good health and lost to poor health. By examining the years spent in poor health over time, 
observations can be made regarding whether years spent in poor health have increased, 
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decreased, or remained the same.  For example, the GBD estimated HALE in 1990 and 2010 in 
the US. During the time period, both life expectancy and HALE at birth increased. Life 
expectancy increased from 75.2 years (95% Uncertainty Intervals (UI) 75.2, 75.2) to 78.2 years 
(95% UI 78.2, 78.3) and HALE increased from 65.8 years (95% UI 64.0, 67.4) to 68.1 years 
(95% UI 66.3, 69.8). However, the gap between HALE and life expectancy also increased so that 
the gap in 1990 was 9.4 years and in 2010 was 10.1 years.2 This finding suggests that although 
people are living longer, the years spent in poor health have also increased.  
3.1.4  Summary 
As population aging continues, interest has grown in understanding how to delay the 
onset of chronic diseases to increase the years spent in good health. Health expectancy outcomes 
can aid in research in this area by highlighting years spent in good health.  Given that CVD and 
cancer contribute to a large burden of morbidity and mortality, targeting the prevention of these 
diseases could extend the number of years lived in health free of these diseases.   
3.2  Overview of CVD and cancer 
3.2.1  Overview of cardiovascular disease 
In 2014, an estimated 92.1 million (36.6%) people in the US had been diagnosed with 
CVD.30 The leading causes of death from CVD are CHD (44%) and stroke (17%).30 As 
referenced by acute care hospitalizations, CHD is the most frequent, followed by stroke and 
HF.31 Likelihood of developing CVD increases with age and with presence of multiple risk 
factors.30 Many CVDs share the same risk factors including high blood pressure, obesity, adverse 
blood lipid profiles, diabetes, smoking, low levels of physical activity, excess alcohol 
consumption, and family history of CVD.31  
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Cardiovascular diseases include disorders of the heart and the arteries supplying blood 
flow to the heart, brain, and peripheral tissues.31 A common underlying factor in the 
development of many CVDs is atherosclerosis.  Atherosclerosis is a process that alters the walls 
of the medium and large arteries that supply the heart, brain, lower extremities, and the aorta.31 
The early stages of atherosclerosis are characterized by raised lesions typically at sites of fatty 
streaks. The lesions can develop into fibrous plaques and eventually become stenotic or 
complicated lesions that restrict blood flow.31  In industrialized societies atherosclerotic lesions 
begin in childhood but the development of a CVD manifestation associated with atherosclerosis 
usually occurs later in life.31  
CHD is syndrome that includes angina pectoris, acute myocardial infarction (MI), 
complications following acute MI, and chronic ischemic heart disease.31 About 16.5 million 
Americans (6.3%) have CHD.30 Both CHD death rates and incidence rates have declined over 
the past decade.30  
Stroke refers to sudden neurologic deficits as a consequence of impaired blood flow in 
the brain.31 In the US, 2.7 million Americans have had a stroke (2.7%).30 Close to 800,000 
people are estimated to have a new or recurrent stroke each year - 77% of these are first attacks 
and 23% are recurrent attacks. Most strokes are ischemic (87%), 10% are intracerebral 
hemorrhage, and 3% are subarachnoid hemorrhage.30 Multiple studies suggest stroke incidence 
and mortality has declined over time for both men and women and all race and age groups.  
HF is a syndrome that results from impairment of the pumping function of the left 
ventricle of the heart or an increase in stiffness of the ventricles. About 6.5 million Americans 
have HF (National Health and Nutrition Examination Survey (NHANES) 2011-2014 data 
cycle).30 Incidence rates are highest for African Americans compared to whites.30 Case fatality is 
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high for people diagnosed with heart failure. About 50% of people diagnosed with heart failure 
will die within five years.30 
3.2.2  Overview of cancer 
In the US in 2018, over 15.5 million people had ever been diagnosed with cancer and 
about 1.69 million new cancer cases are predicted to be diagnosed in 2018.32  
The leading cancers for men are prostate (19%), lung and bronchus (14%), and colon and rectum 
(9%). The leading cancers for women are breast (30%), lung and bronchus (12%), and colon and 
rectum (8%).5  Most cancer is diagnosed in older adults, as about 87% occurs in people 50 years 
and older.5 The cancer death rate increased over the 20th century due to smoking and peaked in 
1991 at 215 deaths per 100,000 persons. This death rate has declined to 161 deaths per 100,000 
persons in 2014 due to declines in death rates from lung, colorectal, breast, and prostate cancer.5   
Cancer is a group of related diseases that results from the uncontrolled growth and spread 
of abnormal cells.5 Normal cells can become damaged by factors that alter cell DNA that can 
arise from genetic factors and external agents such naturally occurring exposures (i.e. ultraviolet 
radiation), lifestyle factors (i.e. diet), workplace and household exposures, medical treatments 
(i.e. hormone drugs), and pollution.33 The cancerous cells can progress to pre-cancerous lesions 
and to a malignant tumor. Metastasis occurs if cells break away from a tumor and move to other 
areas of the body to start a new site and continue growing.34  
Colorectal cancer is the third leading incident cancer and accounts for 9% and 8% of 
detected cancers among men and women, respectively.5 Over 1.3 million people in the US have 
been diagnosed with colorectal cancer.35 Colorectal cancer incidence and death rates have 
declined for several decades due improvements in cancer screening and treatment.5 Risk factors 
for colorectal cancer include obesity, low levels of physical activity, smoking, high consumption 
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of red or processed meat, low calcium intake, moderate to heavy alcohol intake, low intake 
fruits, vegetables and whole grain fiber, family history of colorectal cancer, and type 2 diabetes.5 
Lung cancer is the second leading cancer for men and women, accounting for 14% and 
13% of incident cancers, respectively.5 Over 541,000 people in the US have been diagnosed with 
lung cancer.35 The incidence rates have declined since 1980’s for men and 2000’s for women, 
due to reductions in smoking.  Similarly, lung cancer death rates have also declined.5 Risk 
factors for lung cancer include smoking, exposure to environmental factors (radon gas, asbestos), 
certain metals (chromium, arsenic, cadmium), radiation, air pollution, and diesel exhaust.5  
Among women, breast cancer is the most frequently detected cancer accounting for about 
30% of incident cancers.5 Over 3.4 million people in the US have been diagnosed with breast 
cancer.35 Invasive breast cancer incidence rates for white women have remained stable from 
2004 to 2013 and rates for African American women have increased 0.5% to an incidence rate 
very similar to that of white women.5 The mortality rate for breast cancer has declined by 38% 
from 1989 to 2014 due to better detection and treatment.5 Risk factors for breast cancer include 
overweight/obesity, postmenopausal hormone use, low levels of physical activity, alcohol, 
family history of breast or ovarian cancer, inherited mutations (such as in BRCA1, BRCA2), high 
breast tissue density, high dose radiation to the chest when young, and reproductive history 
factors (long menstrual history, never having children, and having first child after age 30). 5 
Among men, prostate cancer is the leading cancer accounting for 19% of deaths due to 
cancer.5  The prevalence of prostate cancer in 2015 was 2.8 million in the US.35 The incidence 
rate for prostate cancer increased in late 1980’s because of higher uptake of prostate screening 
(with prostate-specific antigen (PSA) test).  The rate declined in the year 2000 and has continued 
to decline mostly due to guideline changes in 2008 to stop routine PSA screening.5 The age-
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adjusted incidence rate is higher for African American men (203.5 cases per 100,000 population) 
than white men (121.9 cases per 100,000 population).36 Well-established risk factors for prostate 
cancer include age, African ancestry, family history of prostate cancer, and inherited conditions 
(Lynch syndrome and BRCA1 and BRCA2 mutations).5   
3.2.3  Summary 
Much progress has been made over the decades in reducing incidence rates and 
improving survival for the leading CVDs and cancers. Common to these diseases are many of the 
same risk factors. For example, low levels of physical activity are a risk factor for each disease 
described. Interventions to improve habitual physical activity may be one strategy to increase 
years spent in health by preventing and/or delaying the onset of these leading diseases.  
3.3  Physical activity and sedentary behavior 
3.3.1  Physical activity  
Physical activity is defined as “any bodily movement produced by skeletal muscles that 
results in energy expenditure” and includes activity that occurs while working, commuting, 
performing household chores, and participating in any planned exercise or sport.37  The most 
commonly used method for gathering physical activity data in epidemiological studies is self-
report questionnaires37 and leisure-time (e.g., discretionary) activity is the domain most often 
asked about.4  
Physical activity is often measured by collecting information on the frequency (how often 
activity is done), duration (how long activity lasted), and intensity (the level of effort or work 
done to perform the activity).38 Intensity is measured as absolute or relative intensity. Absolute 
intensity is the rate of work performed and does not account for individual fitness to perform the 
work. In contrast, relative intensity accounts for an individual cardiorespiratory fitness level to 
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perform the work. Relative intensity is measured as perceived exertion, percent of aerobic 
capacity (VO2max), or percent of maximum heart rate.
38 The absolute intensity of physical 
activities is expressed as the rate of energy expenditure and metabolic equivalent of task (MET) 
is widely used to measure intensity.39 A MET is the ratio of the rate of energy expended during 
an activity to the rate of energy expended at rest while awake, which is equivalent to 1 MET. 39 
Physical activities have been classified into three intensity levels – light (1.1 – 2.9 METs), 
moderate (3.0 – 5.9 METs), and vigorous (> 6.0 METs). For example, a brisk walk at 3 miles per 
hour expends 3.3 METs and is classified as a moderate intensity activity.  If a person engages in 
30 minutes of a 3.3 MET activity (30 minutes X 3.3 METs) then 99 MET-minutes have been 
expended. Table 3 includes examples of types of physical activities by intensity level. The use of 
absolute intensity provides a standardized way to measure physical activity intensity across 
populations and studies, and to measure associations of physical activity with health outcomes.38  
 
Table 3. Types of activities according to their MET values. 
Type of Intensity Types of Activities 40 
Light intensity 1.1 
– 2.9 METs 
Light effort in household tasks like mopping, standing, cleaning, 
sweeping, carrying out trash, washing dishes; stretching; yoga 
(Hatha) 
Moderate 
intensity 3.0 – 5.9 
METs 
Walking; household activities with moderate effort; light moderate 
effort gardening like digging, spading; mowing lawn with moderate 
effort; weight training; pilates; water aerobics; yoga (Power) 
Vigorous intensity 
> 6.0 METs 
Running, bicycling, general aerobic dance, rowing 
 
In 2008 and 2018, the US Department of Health and Human Services released physical 
activity guidelines for all Americans. Based on their review of the physical activity literature, 
substantial health benefits were achieved with 500 to 1,000 MET-minutes per week (8.3 to 16.7 
MET-hours per week) of aerobic physical activity.39, 41  The committee concluded there was a 
dose response relationship so that some health benefits were observed for less than 500 MET-
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minutes and more benefits were observed for more than 1,000 MET-minutes. The committee put 
forth the recommendation for adults for aerobic physical activity to engage in at least 150 
minutes per week of moderate intensity or 75 minutes of vigorous intensity, or the equivalent 
combination.39, 41 The committee also suggested that for additional health benefits adults should 
engage in 300 minutes of moderate intensity per week or 150 minutes of vigorous intensity or the 
equivalent combination of moderate and vigorous activity.  
Below is a table that summarizes how walking at 3.3 METS following the guidelines 
translates into minutes spent per day, MET-minutes per week, and MET-hours per week (Table 
4). Throughout the physical activity literature, different metrics are used and this table can be 
helpful for interpreting different specifications of physical activity.  
 
Table 4. How walking at 3.3 METs at different guideline levels translates into minutes per 
week, minutes per day, MET-minutes per week, and MET-hours per week 






Minimum amount to 
meet PAG guidelines 
150 min per week 21.4 495 8.25 
Double guidelines 
(additional health 
benefits per the PAG) 
300 min per week 42.9 990 16.5 
Triple guidelines 450 min per week 64.3 1485 24.8 
Abbreviations: PAG= 2008 physical activity guidelines 
 
The National Health Interview Survey (2011-2014) asked about leisure time aerobic 
physical activity. Overall, 49.9% of respondents interviewed (adults > 18 years) reported enough 
activity to be classified as meeting the aerobic activity federal guidelines.42 Men were more 
likely than women to meet the guidelines and whites were more likely than African Americans to 
meet the guidelines. In examining across gender-race categories, white males were the most 
likely to meet guidelines (54.1%), followed by African American males (49.6%), white females 
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(48.4%), and African American females (35.8%).42  These data were based on self-report of 
physical activity. Studies that have compared self-report and accelerometer measured physical 
activity show that the amount of physical activity that is self-reported is higher than objectively 
measured physical activity.43, 44 For example, in an analysis of the 2005-2006 NHANES cycle, 
adults who self-reported meeting guidelines of 150 minutes of moderate-to-vigorous physical 
activity (MVPA) per week expended approximately 57 minutes a week in MVPA as measured 
by accelerometer.43 
3.3.2  Sedentary behavior  
Sedentary behavior is distinct from physical activity – sedentary behaviors are any 
waking behaviors that expend little energy expenditure (< 1.5 metabolic equivalent of task 
(METs)) while in a sitting, reclining, or lying posture.45, 46 Examples include sitting at work, 
sitting or lying to watch TV, sitting while commuting, and sitting to do other recreational 
activities like reading, knitting, or playing cards.47, 48 Most energy expenditure throughout a day 
is from light activity (Figure 2) and research suggests that time spent in light activities has been 
replaced by sedentary behaviors due to environmental and technological changes in society.48, 49 
Time spent in sedentary behavior can be measured as overall sedentary time across a day, the 
amount of time spent in specific behaviors (TV, computer use), or time occurring in a specific 
domain (work, leisure, domestic, transport). Often, time spent in sedentary behaviors is collected 
by self-report questionnaires or activity logs, but also can be estimated from accelerometers.47   
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Figure 2. Accelerometer-measured distribution of time spent in sedentary, light-intensity, 
and moderate intensity according to quartile of sedentary time, NHANES 
 
Reprinted from Diabetes Research and Clinical Practice, 97, Dunstan DW, Howard, B., Healy, 
G. N., Owen, N, Too much sitting--a health hazard, 368-376, (2012), with permission from 
Elsevier. 
 
The NHANES 2003-2004 data collection cycle used accelerometers and Matthews et al. 
estimated total time spent in sedentary behavior using these data.50 On average, US adults spend 
7.7 hours/day in sedentary behavior. The prevalence of sedentary behavior is higher with older 
age groups. For example, adults 40-49 years spent 7.55 hours per day sedentary, adults 50-59 
years spent 7.87 hours per day sedentary, those 60-69 spent 8.41 days sedentary, and those 70-85 
years spent 9.28 hours per day sedentary.50   
One of the most common sedentary behaviors reported by adults is television viewing.51 
On average Americans spend about 3 hours a day watching television. Men spent more time 
watching TV than women (men weekday 2.71 hours/day, weekend 3.75 hours/day, women 
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weekday 2.43 hours/day, weekend 2.86 hours/day) and the prevalence is higher for older age 
groups.51 
3.4  Epidemiology of physical activity and sedentary behavior with CVD and cancer  
The purpose of this dissertation is to examine the association between physical activity 
and sedentary behavior with years lived free of CVD and cancer. Because of the sparse research 
in this area, the broader physical activity and sedentary behavior literature will be summarized 
with respect to the outcomes included in this dissertation. For example, the health expectancy 
outcomes combine incidence and mortality into a summary measure. Therefore, the literature on 
physical activity and sedentary behavior with all-cause mortality and incidence of each disease is 
briefly summarized.  
3.4.1  All-cause mortality 
3.4.1.1  Physical activity and all-cause mortality 
A robust body of evidence provides support that physical activity reduces the risk of all-
cause mortality.52, 53 Multiple sources suggest that the relationship between physical activity and 
mortality is curvilinear. For example, Arem et al. examined leisure time MVPA and all-cause 
mortality in an analysis of pooled data from 6 studies in the National Cancer Institute (NCI) 
Consortium Cohort. These authors illustrated that there was a mortality reduction of 20% (hazard 
ratio (HR)=0.80 (95% confidence interval (CI) 0.78, 0.82)) even below the recommended 
guidelines of 7.5 MET-hours per week compared to no activity, a 31% reduction at meeting and 
doubling guidelines (7.5-<15 MET-hours per week HR=0.69, (95% CI 0.67, 0.70)) and further 
risk reduction at higher levels of physical activity.54 Both this study and the review by the 2018 
physical activity guidelines committee suggest a curvilinear relationship between level of 
moderate-to-vigorous physical activity and risk reduction in all-cause mortality, such that a large 
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benefit is observed at lower levels of activity and then risk reduction continues at higher levels of 
activity.41 
Further research suggests that people who engage in more physical activity have a longer 
life expectancy compared to those who engage in less activity.55, 56 For example, Moore et al. 
used the NCI cohorts and examined how different leisure time physical activity levels compared 
to none were associated with life expectancy: the authors observed at a physical activity level of 
0.1-3.74 MET-hours per week a gain of 1.8 years of life (95% CI 1.6, 2.0), at 3.75-7.4 MET-
hours per week a gain of 2.5 years, at 7.5-14.9 MET-hours per week a gain of 3.4 years, and a 
similar increase of 4 years at 15.0-22.4 and >22.5 MET-hours per week.55  
3.4.1.2  Sedentary behavior and all-cause mortality 
Meta-analyses and review articles have consistently found an association between greater 
amounts of sedentary behavior and increased risk of all-cause mortality.57-59 Biswas et al. 
included 13 studies and estimated a risk ratio of 1.22 (95% CI 1.08, 1.38) for self-reported high 
sedentary behavior compared to low with the risk of all-cause mortality (these analyses were 
adjusted for physical activity).57 In another meta-analysis six studies were included and 
examined daily sitting time and observed a hazard ratio of mortality of 1.02 (95% CI 1.01, 1.03) 
per hour increment in sitting time with adjustment for physical activity. This analysis suggested 
that the relationship was non-linear because the authors did not observe an increased risk per 
hour of sitting time at < 7 hours per day, but then observed an increased risk of 5% for each hour 
increment at > 7 hours per day.60  
Evidence suggests that one of the most popular sedentary activities, TV viewing, has 
been associated with an increased risk of mortality.61, 62 For example, Sun et al. included ten 
studies in a meta-analysis and observed a risk ratio (RR) of 1.33 (95% CI: 1.20, 1.47) for high 
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TV viewing time compared to low TV viewing time with the risk of all-cause mortality.61 In this 
meta-analysis, the authors examined the dose response relationship and observed an increased 
risk for all-cause mortality at about 4 hours per day of TV viewing.  
3.4.2  CVD 
3.4.2.1  Physical activity and CVD 
A large body of evidence supports the beneficial effect of physical activity on reducing 
the risk of CVD mortality and incidence.54, 63-65 The dose response relationship of physical 
activity with CVD suggests a large risk reduction at moving from inactive to some activity.  For 
example, in a meta-analysis on CHD and physical activity, the authors observed for those that 
met US aerobic physical activity guidelines (approximately 8 MET-hours per week) compared to 
no aerobic physical activity, a 14% lower risk of CHD (RR=0.86 (95% CI 0.77, 0.96) and for 
those that met advanced guidelines (about 16 MET-hours per week) a 20% lower risk (RR=0.80 
(95% CI 0.74, 0.88).66  Using almost identical physical activity categories, a meta-analysis on 
HF observed a 10% lower risk of HF for participants who engaged in about 8.25 MET-hours per 
week compared to no physical activity (HR=0.90 (95% CI 0.87, 0.92)) and at 16.5 MET-hours 
per week a 19% reduction in HF risk (HR=0.81 (95% CI 0.77, 0.86)).67 One recent meta-analysis 
examined the dose response relationship of physical activity with ischemic stroke and suggested 
a curvilinear relationship with the largest risk reduction in moving from no activity to some 
activity and continued risk reduction at higher levels of activity.68 Other meta-analyses suggest 
little difference of the relationship between physical activity and stroke subtype.69, 70  For 
example, Wendel-Vos et al. (19 studies) observed similar estimates for both hemorrhagic (RR = 
0.74 (95% CI 0.57, 0.96)) and ischemic stroke (RR = 0.79 (95% CI 0.69, 0.91)) when comparing 
highest levels of leisure-time physical activity to the lowest level.69  
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3.4.2.2  Sedentary behavior and CVD 
Similar to the findings of the association of sedentary behavior with all-cause mortality, 
greater amounts of sedentary behavior are associated with increased risk of CVD incidence and 
CVD mortality. Biswas et al. conducted a meta-analysis and observed for the highest levels of 
sedentary behavior compared to the lowest level of sedentary behavior a risk ratio of 1.14 (95% 
CI 1.00, 1.30) and 1.15 (95% CI 1.07, 1.24) for CVD incidence (3 studies) and CVD mortality (7 
studies).57  In another meta-analysis that examined TV viewing and incident CVD (4 studies), the 
authors observed an increased risk of CVD with more TV viewing per day compared to less.62 In 
a more recent analysis Young et al. examined a measure of TV, reading, and sitting at computer 
time and found an increased risk of incident HF (hazard ratio= 1.27 (95% CI 1.15, 1.41)) in 
comparing highest levels of sedentary behavior with the lowest levels.71 
A further examination of the dose response relationship of sedentary behavior with CVD 
suggests a non-linear relationship. In a meta-analysis (9 cohort studies) of the relationship of 
sedentary behavior (assessed as self-reported sitting time) increased CVD risk was observed at 
the highest levels of sedentary behavior (median 12.5 hours/day) (HR=1.14 (95% CI 1.09, 1.19)) 
but not at intermediate levels of sedentary behavior (median 7.5 hours/day, HR=1.02 (95% CI 
0.96, 1.08)) compared to the lowest levels of sedentary behavior (median 2.5 hours/day).9 The 
authors further explored continuous measures of sedentary behavior and observed the 
relationship was non-linear with little increase in risk at less than 10 hours per day but an 
increased risk starting at more than 10 hours of sedentary behavior per day.9   
3.4.2.3  Years lived free of CVD 
The previous review of how physical activity and sedentary behavior were associated 
with CVD focused on measures of risk. Health expectancy outcomes estimate years lived in 
   21 
good and poor health. Currently, three studies have examined physical activity and a health 
expectancy outcome of years lived with and without CVD. Two studies were conducted with the 
Framingham cohort 11, 12 and the other report analyzed 3 European cohorts.10 Of the three studies, 
two examined how multiple risk factors, including physical activity, influenced years lived with 
and without CVD 11 10 and the other study included only physical activity and not other health 
behaviors.12 
In both Framingham studies, participants were asked how long they spent in various 
activities and each activity was assigned a weight based on estimated oxygen consumption to 
reflect METs: sleeping (weight=1), resting (weight=1.1), or engaged in light (weight=1.5), 
moderate (weight=2.4), and heavy (weight=5) physical activity. A daily activity score was 
summed and grouped into tertiles (low =< 30, moderate=30-33, high =>33).11, 12 In the European 
study only vigorous physical activity was assessed with a question on participating in any 
vigorous activity at least once per week to cause increased breathing or sweating.10  Across the 
three studies, assessment of CVD was similar and is summarized in Table 5.  
All studies estimated life expectancy at age 50. Across all studies, participants who 
engaged in more physical activity had longer life expectancy, more years free of CVD, and more 
years lived with CVD compared to participants who engaged in less physical activity. For both 
men and women, the largest portion of life expectancy was spent as CVD-free. In all the studies, 
women had longer life expectancy than men. Although women had longer life expectancy, the 
difference in the number of years lived CVD-free by physical activity level was similar for both 
genders. For example, Franco et al. 12 estimated that men who engaged in high levels of physical 
activity could expect to live 22.8 years (95% CI 21.6, 23.9) free of CVD, which was 3.2 years 
(95% CI 1.9, 4.3) more than men who engaged in low levels of physical activity (19.7 years 
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CVD-free (95% CI 18.7, 20.6)) (Table 6). Women who engaged in high levels of physical 
activity could expect to live 29.4 years (95% CI 28.2, 30.6) free of CVD, which was 3.3 (95% CI 
2.0, 4.5) more years than women who engaged in low levels of physical activity (26.1 years 
CVD-free (95% CI 25.3, 27.0)).12 In both of the other studies 10, 11, similar associations were 
observed in which the difference in CVD-free life expectancy by physical activity level was 
similar for both men and women.  
These studies are promising in their examination of how years spent free of CVD can be 
attained by engagement in physical activity. However, there are limitations of this research to 
consider. The Framingham studies 11, 12 used a physical activity measurement that weights 
activities by intensity, giving greater weight to high intensity, but the results do not provide the 
number of MET hours per week associated with CVD-free years, which is easier to interpret. 
O’Doherty et al. 10 asked only about vigorous activity, but prevalence estimates suggest that a 
low proportion of people engage in vigorous activity.44 It would be more informative to know 
how MET hours per week spent in both moderate and vigorous intensity activity influence 
disease free years. The two studies conducted in the US were with the Framingham cohort 11, 12, 
which is primarily white. Although 80% of US adults 65 and older are non-Hispanic white, the 
ethnic and racial diversity of older adults is projected to increase.72 It is necessary to include a 
more diverse population in these types of studies to provide research on how to increase years 
spent in good health for a range of racial and ethnic older adults.   
Although two of these studies 10, 11 included other behaviors that are linked to CVD (such 
as smoking, obesity, and alcohol), none of these studies examined sedentary behavior.  Given the 
consistent evidence of how sedentary behaviors are linked to an increased risk of CVD, and the 
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large amount of time people spend in sedentary behaviors, this is another behavior that may 
influence years spent CVD-free.   
 









Assessment of Physical 
Activity 








Self-report of time 
spent per day in at 
various activities; 
weights like METS 
applied, daily score 
summed and 
categorized into tertiles 
Death, incident and fatal CVD: 
CHD (angina, coronary 
insufficiency, MI, sudden or 
not sudden death), HF, stroke, 
transient ischemic attack, 
intermittent claudication; 
assessed by committee of 
physicians  
For men & women, higher amounts 
of PA associated with longer LE 
and years CVD-free 
Women had longer LE then men; 
but the difference in LE & CVD 
free years between high vs. low PA 








Self-report time spent 
per day in at various 
activities; weights like 
METS applied, daily 
score summed and 
categorized into tertiles 
Death, incident and fatal CVD: 
CHD (angina, coronary 
insufficiency, MI, sudden or 
not sudden death), HF, stroke, 
transient ischemic attack, 
intermittent claudication; 
assessed by committee of 
physicians  
For men & women, higher amounts 
of PA associated with longer LE 
and years CVD-free 
Women had longer LE then men but 
the difference in LE & CVD free 
years between high vs. low PA was 






varies for each 
study, all age 
50+ 
Self-report of any 
vigorous activity at 
least once a week to 
cause increased 
breathing/sweating 
Death from death register; 
CVD as acute coronary event 
or stroke 
For men & women, higher amounts 
of PA associated with longer life 
expectancy and years CVD-free 
Women had longer LE then men but 
the difference in LE & CVD-free 
years between vigorous vs. no 
vigorous PA was similar by gender 
aThree cohorts from the Consortium on Health and Ageing Network of Cohorts in Europe and the United States (CHANCES) were 
included in the O’Doherty analysis. These include a cohort from the Research Centre for Prevention and Health (RCPH) in Denmark, 
the ESTHER study a population-based cohort based in the state of Saarland, Germany, and a cohort from the municipality of Tromsø, 
Norway. Abbreviations: CHANCES= Consortium on Health and Ageing Network of Cohorts in Europe and the United States; CHD= 
coronary heart disease, CVD= cardiovascular disease, HF= heart failure, LE= life expectancy, MET= metabolic equivalent of task, 
MI= myocardial infarction, PA= physical activity 




Table 6. Estimates of total life expectancy and CVD-free life expectancy by level of physical activity. 
  Total LE at age 50, 
years (95% CI) 
Difference, years 
(95% CI) 
LE free of CVD at age 50, 
years (95% CI) 
Difference, years 
(95% CI) 
Franco 2005, mena     
high PA 29.9 (29.0, 31.0) 3.7 (2.6, 4.8) 22.8 (21.6, 23.9) 3.2 (1.9, 4.3) 
medium PA 27.6 (26.6, 28.7) 1.3 (0.3, 2.3) 20.8 (19.6, 21.9) 1.1 (-0.02, 2.1) 
low PA 26.2 (25.4, 27.1) ref 19.7 (18.7, 20.6) ref 
Franco 2005, womena 
    
high PA 36.0 (35.0, 37.1) 3.5 (2.4, 4.6) 29.4 (28.2, 30.6) 3.3 (2.0, 4.5) 
medium PA 34.0 (33.0, 35.0) 1.5 (0.4, 2.5) 27.4 (26.4, 28.5) 1.3 (0.1, 2.4) 
low PA 32.5 (31.7, 33.3) ref 26.1 (25.3, 27.0) ref 
Nusselder 2009, menb 
    
high PA 30.0 (29.0, 31.0) 3.5 (2.5, 4.6) 22.8 (21.7, 23.9) 3.0 (1.8, 4.3) 
medium PA 27.7 (26.8, 28.8) 1.3 (0.3, 3.2) 20.8 (19.7, 22.0) 1.1 (0.0, 2.2) 
low PA 26.4 (25.7, 27.3) ref 19.7 (18.9, 20.6) ref 
Nusselder 2009, 
womenb 
    
high PA 36.1 (35.0, 37.2) 3.4 (2.3, 4.5) 29.4 (28.2, 30.6) 3.1 (1.9, 4.3) 
medium PA 34.1 (33.2, 35.1) 1.5 (0.5, 2.5) 27.6 (26.6, 28.7) 1.3 (0.2, 2.4) 
low PA 32.7 (31.9, 33.5) ref 26.3 (25.5, 27.1) ref 
O'Doherty 2016 RCPH, menc,d 
   
vigorous PA 25.0 (23.2, 26.9) 3.1 (1.4, 5.1) 22.0 (20.4, 23.9) 2.5 (0.8, 4.3) 
no vigorous PA 21.9 (20.9, 22.8) ref 19.5 (18.5, 20.4) ref 
O'Doherty 2016 RCPH, womenc,d 
   
vigorous PA 29.5 (27.1, 31.7) 3.5 (1.4, 5.4) 26.4 (24.3, 28.5) 2.9 (0.9, 4.8) 
no vigorous PA 26.0 (24.8, 27.3) ref 23.5 (22.4, 24.9) ref 
O'Doherty 2016 ESTHER, menc,d 
   
vigorous PA 34.8 (31.7, 40.4) 6.8 (4.3, 10.7) 27.0 (25.8, 28.3) 4.3 (3.0, 5.7) 
no vigorous PA 28.1 (26.3, 31.2) ref 22.7 (21.7, 23.6) ref 
O'Doherty 2016 ESTHER, womenc,d 
   
vigorous PA 42.3 (38.6, 47.4) 6.9 (4.5, 9.9) 34.8 (33.1, 36.6) 4.8 (3.3, 6.4) 
no vigorous PA 35.3 (33.1, 39.0) ref 29.9 (28.9, 31.1) ref 
O'Doherty 2016 Tromsø, menc,d 
   




  Total LE at age 50, 
years (95% CI) 
Difference, years 
(95% CI) 
LE free of CVD at age 50, 
years (95% CI) 
Difference, years 
(95% CI) 
vigorous PA 27.8 (27.1, 28.4) 3.2 (2.4, 3.9) 23.0 (22.4, 23.7) 2.5 (1.7, 3.2) 
no vigorous PA 24.6 (24.0, 25.1) ref 20.6 (20.0, 21.1) ref 
O'Doherty 2016 Tromsø, womenc,d 
   
vigorous PA 32.6 (31.7, 33.4) 3.5 (2.7, 4.3) 28.9 (28.1, 29.7) 2.9 (2.1, 3.8) 
no vigorous PA 29.1 (28.6, 29.5) ref 26.0 (25.5, 26.5) ref 
aFranco et al. controlled for age, sex, smoking, exam date, and comorbidity at baseline (cancer, diabetes, left ventricular hypertrophy, 
arthritis, ankle edema or any pulmonary disease).  
bNusselder et al. estimates controlled for comorbidity at baseline (cancer, diabetes, left ventricular hypertrophy, arthritis, ankle edema 
or any pulmonary disease), exam date, and smoking. 
cO’Doherty et al. controlled for age, history of diabetes, hypertension, total/HDL cholesterol ratio, smoking, BMI, alcohol. 
dThree cohorts from the Consortium on Health and Ageing Network of Cohorts in Europe and the United States (CHANCES) were 
included in the O’Doherty analysis. These include a cohort from the Research Centre for Prevention and Health (RCPH) in Denmark, 
the ESTHER study a population-based cohort based in the state of Saarland, Germany, and a cohort from the municipality of Tromsø, 
Norway. 
Abbreviations: CI= confidence interval, CVD= cardiovascular disease, LE= life expectancy, PA= physical activity 
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3.4.3  Cancer 
3.4.3.1  Physical activity and cancer 
In 2007 the World Cancer Research Fund (WCRF) and American Institute for Cancer 
Research (AICR) reviewed literature on the epidemiological evidence of the association of 
physical activity and cancer.73 This report concluded that physical activity was associated with a 
lower risk of colon cancer, postmenopausal breast cancer, and endometrial cancer. A recent 
meta-analysis 7 included 26 types of cancer and observed that high levels of physical activity 
compared to low levels was associated with a lower risk for 13 types of cancer (esophageal 
adenocarcinoma, liver, lung, kidney, gastric cardia, endometrial, myeloid leukemia, myeloma, 
colon, head and neck, rectal, bladder, and breast). 
Consistent findings suggest physical activity is protective against breast cancer but may 
vary by menopausal status. A recent meta-analysis by Wu et al. 74 included 31 studies and 
observed a risk ratio of 0.87 (95% CI 0.83, 0.92) for highest compared to the lowest level of total 
physical activity for the risk of breast cancer. When separately examining premenopausal and 
postmenopausal breast cancer, the Wu et al. meta-analysis 74 and the Continuous Update Report 
(CUP) 75 (conducted by WCRF and AICR) review observed similar estimates for 
postmenopausal breast cancer (Wu et al. RR=0.87 (95% CI 0.87, 0.92), CUP review RR=0.87 
(95% CI 0.7, 0.96)). These two reviews had inconsistent results about premenopausal breast 
cancer - Wu et al. observed a strong association but the CUP review observed a weak 
association. 74, 75  
Consistent evidence suggests that physical activity is beneficial at reducing the risk of 
colon cancer. In a meta-analysis of 22 prospective cohort studies, the authors observed a risk 
ratio of 0.83 (95% CI 0.78, 0.88) for the highest level of physical activity compared to lowest 
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level with the risk of colon cancer.76 Similar estimates were observed for men (RR=0.76 (95% 
CI 0.71, 0.82)) and women (RR=0.79 (95% CI 0.71, 0.88)).76 In studies that separately examined 
physical activity with colon and rectal cancers, strong association were observed for colon cancer 
but not rectal.77  
The findings on the association of physical activity with prostate cancer risk have 
suggested a weak relationship. Liu et al. conducted a meta-analysis of 19 cohort studies and 
observed weak protective associations for risk of prostate cancer by level of physical activity 
(RR=0.95 (95% CI, 0.90, 1.00).78 The CUP report in 2014 found similar estimates as Liu et al.79. 
With the NCI Cohort Consortium Moore et al. estimated an HR of 1.05 (95% CI 1.03. 1.08)) for 
the highest level of physical activity compared to lowest levels for risk of prostate cancer.7 The 
findings for how these relationships vary by race has been mixed. For example, Liu et al. 
estimated weaker association for whites (RR=0.98 (95% CI 0.93, 1.04)) and much stronger 
associations for African Americans (RR=0.62 (95% CI 0.24, 1.61)) but this estimate was based 
on two studies.78 However, in Moore et al. the authors observed no difference by race.7 
In a recent meta-analysis by Zhong et al. on physical activity and incident lung cancer, 18 
studies were included and physical activity was inversely associated with a reduced risk of lung 
cancer.80 Compared to low levels of physical activity, the authors observed a risk ratio of 0.87 
(95% CI 0.84, 0.90) for moderate levels of activity and a risk ratio of 0.75 (95% CI 0.68, 0.84) at 
high levels of activity for the risk of lung cancer.80 In a pooled NCI cohort analysis, similar 
associations were observed for the inverse association of physical activity with incident lung 
cancer.7 
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3.4.3.2  Sedentary behavior and cancer 
Consistent evidences suggests that higher amounts of time spent in sedentary behavior 
are associated with an increased risk of certain cancers compared to lower amounts of time spent 
in sedentary behavior.8, 81, 82  In comparing the highest to lowest levels of sedentary behavior (43 
studies) a meta-analysis observed an increased risk for colon cancer (RR=1.28 (95% CI 1.13, 
1.45)), endometrial cancer (RR=1.36 (95% CI 1.15, 1.60)), and lung cancer (RR=1.21 (95% CI 
1.03, 1.43)) and weak associations for breast cancer (RR=1.03; (95% CI 0.95, 1.12)), prostate 
cancer (RR=1.10 (95% CI 0.93, 1.30)) and others (ovarian, gastric, esophageal, testicular, renal 
cell, and non-Hodgkin lymphoma).8 While this review noted weak findings for breast cancer, 
another meta-analysis noted an increased risk for breast cancer (RR=1.17 (95% CI 1.03, 1.33) for 
high compared to low sedentary behavior.81  
Fewer studies have been conducted with a measure of TV viewing as a proxy indicator 
for sedentary behavior. The results have been mixed. For lung cancer, two studies have been 
conducted and one observed an increased risk for lung cancer for men at viewing TV for four 
hours or more (RR=1.36 (95% CI 1.04, 1.79)) but null findings were observed with women 
(RR=1.01 (95% CI 0.66, 1.59))83 and the other study, among a cohort of non-smokers, had null 
findings comparing TV viewing time of 5 hours or more to less than 3 hours per day (RR=1.06 
(95% CI 0.77, 1.46)).84 For prostate cancer, one study has been conducted and the authors 
observed null findings comparing 7 hours of viewing versus less than 1 hour per day. 85 A recent 
meta analysis included 6 studies on TV viewing time with breast cancer risk and observed null 
findings (RR=1.07 (95% CI 0.96, 1.20).86  A meta-analysis that included two studies on TV 
viewing and examined the risk of colon cancer found a risk ratio of 1.54 (95% CI 1.19, 1.98)8 for 
the highest level of TV viewing compared to the lowest levels. Similarly, a recent study with the 
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UK Biobank cohort observed in comparing > 5 hours of TV viewing a day with < 1 hour a day 
an increased risk of colorectal cancer (RR=1.32, 95% CI 1.04, 1.68). 87 
3.4.3.3  Years lived free of cancer 
To date, none of the health expectancy studies have included cancer as an outcome, 
although cancer is one of the leading causes of death. Consistent evidence suggests that physical 
activity and sedentary behaviors are linked to cancer suggesting that this is another area that 
should be examined on how to increase years spent in good health.  
3.4.4 Summary 
In summary, physical activity is consistently found to reduce the risk of all-cause 
mortality, and the incidence of CVD and certain cancers. Also, higher amounts of sedentary 
behavior are found to increase the risk of mortality, CVD, and certain cancers. The research on 
how these behaviors are related to health expectancy outcomes, such as years lived free of CVD 
and cancer, is sparse. Currently, three studies exist on physical activity and CVD outcomes, but 
no studies have been conducted with sedentary behavior or with cancer outcomes. This 
dissertation does address many of the limitations (measurement of physical activity, no sedentary 
behavior measurement, and no cancer outcomes) in the physical activity and health expectancy 
literature.  
3.5  Biological mechanisms of physical activity and sedentary behavior with CVD and 
cancer 
3.5.1  Physical activity and CVD 
Physical activity improves many of the risk factors that are shared across cardiovascular 
diseases. Physical activity is associated with reduced adiposity, improved blood pressure, 
prevention of diabetes, and improvement in lipid profiles.31, 37  In addition to influencing CHD 
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through risk factors, the hypothesized mechanisms for how physical activity is related to CHD 
are related to an increase in myocardial oxygen supply and decrease myocardial work and 
oxygen demand.31 Physical activity helps maintain a normal blood supply to the heart by 
lowering blood cholesterol, thereby decreasing the risk of atherosclerosis. Physical activity also 
lowers heart rate and blood pressure at rest and during exercise, which influence the oxygen 
demand of the heart.37 Another potential mechanism includes a reduced risk of thrombosis due to 
an expansion of plasma volume, which should reduce thickness of the blood and reduce platelet 
stickiness.37 Many of the hypothesized mechanisms for how physical activity influences CHD 
are also hypothesized for stroke. Physical activity reduces the risk of developing atherosclerosis 
and thrombosis, which usually develop before a stroke occurs. In addition to physical activity 
improving many of the CVD risk factors that develop before HF develops, physical activity has 
also been linked to improved cardiac physiological changes. These types of changes include 
improved left ventricular mass, reduced arterial stiffness, and improved left ventricular diastolic 
function. These observations have been observed with athletes as well as in community-dwelling 
population based studies of adults.88  
3.5.2.  Sedentary behavior and CVD 
Higher levels of time spent in sedentary behavior are associated with development of 
many CVD risk factors including obesity, elevated blood glucose, and type 2 diabetes.48 
Sedentary behavior may displace time spent in light intensity activities.48 Light intensity 
activities include activities such as walking slowly, cooking, and cleaning. Engagement with 
more light intensity activity has been associated with better waist circumference, better 
triglycerides, and improved insulin sensitivity.89  
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In addition to affecting CVD risk factors and displacing light intensity activities, a 
mechanism that affects glucose and high density lipoprotein cholesterol (HDL-C) production, 
has been proposed for how sedentary behavior influences cardio-metabolic health.48, 90 During 
episodes of prolonged sitting, large skeletal muscles do not contract and lipoprotein lipase (LPL) 
activity is reduced. LPL activity is essential for glucose and lipid uptake and HDL-C production. 
Experimental studies with rodents suggest that imposed sedentary behavior decreases LPL 
activity in red oxidative muscle sections and white glycolytic sections.90 In contrast, vigorous 
activity such as running, increased LPL activity in white muscle sections but not the red muscle 
sections.90 These findings suggest there may be a distinct pathway for how time spent in 
sedentary behavior affects skeletal muscle LPL activity in large postural muscles. These changes 
in LPL activity may influence cardio-metabolic health independent of the amount of physical 
activity that can increase LPL activity.   
3.5.3.  Physical activity and cancer 
Physical activity may reduce the risk of many cancers through multiple pathways 
including adiposity, sex hormones, insulin, inflammation, and immune function (Figure 3).91 
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Figure 3. Biological mechanisms for how physical activity may reduce cancer risk 
 
 
Reprinted by permission from Springer Nature: Nature Reviews Cancer, Mechanisms linking 
physical activity with cancer, McTiernan A, (2008). 
 
Physical activity may reduce the risk of many cancers by reducing adiposity. Adiposity 
influences the production of many growth factors, such as insulin, insulin-like growth factor 1 
(IGF-1), and leptin, and these factors are suggested to promote the growth of cancer cells.73 The 
adipose tissue is also the site of estrogen synthesis in men and postmenopausal women.73  Higher 
levels of adiposity are related to higher levels of estrogen and increased conversion of androgens 
to estrogen which are linked to increased risk of certain cancers.37 The adipose tissue produces 
inflammatory markers including tumor necrosis factor (TNF) alpha, interleukin (IL)-6, and C-
reactive protein. These markers may promote cancer development.73 Therefore, physical activity 
may reduce adipose tissue and in turn lower levels of inflammatory markers, estrogens and 
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testosterone, and improve insulin sensitivity.91, 92 Cancers potentially associated with this 
mechanism include colon, postmenopausal breast, endometrium, and ovary. 91, 92  
Regarding the hypothesized insulin sensitivity pathway, physical activity improves 
insulin sensitivity, lowers plasma insulin, and lowers glucose levels.92 These changes may be due 
to reduced body fat, increased skeletal muscle mass, and increased glucose transport into 
muscles.  Cancers possibly associated with this mechanism include colon, breast, endometrium, 
ovary, and prostate.91, 92  
Another pathway in which physical activity may reduce cancer risk is through lowering 
levels of estrogens and androgens. This is particularly important for breast and endometrial 
cancers.91 Women with higher levels of estrogens and androgens have a higher risk of 
developing breast and endometrial cancer.34 Observational research suggests active 
premenopausal women and athletes have delayed age at menarche, fewer ovulatory cycles, and 
lower levels of estrogen and progesterone. These factors would contribute to lower life-time 
estrogen and progesterone levels that affect the risk of breast and endometrial cancer.91 For 
postmenopausal women, the main source of estrogen is not from the ovaries but from adipose 
tissue. Research suggests that physical activity helps lower estrogen levels for postmenopausal 
women, which is likely due to physical activity reducing body fat.91 For men, the results are 
inconclusive whether physical activity reduces levels of androgens and the relationship between 
androgens and prostate cancer is unclear.34, 91 Cancers associated with this mechanism include 
breast, prostate, and endometrial cancers.91 
Physical activity may reduce systematic inflammation by lowering levels of 
inflammatory markers like C-reactive protein, interleukin 6, and tumor necrosis factor-alpha. 
These changes may be partly due to fat loss.91  Physical activity may enhance immune function 
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by increasing levels of immune cells in blood (natural killer cells, lymphocytes, monocytes, 
neutrophils) that respond to recognizing and eliminating cancerous cells.91, 92 Both the 
inflammation and immune pathways may affect most cancers.91 
Other hypothesized mechanisms potentially related to colon cancer consider that physical 
activity may increase gut motility and decrease bowel transit time. This could reduce the time 
potential carcinogens are in contact with the lining of the bowel.91, 92  
3.5.4.  Sedentary behavior and cancer 
Most of the hypothesized mechanisms for how sedentary behaviors are associated with 
cancer development focus on the same pathways in which physical activity may reduce cancer 
risk. As previously mentioned, adiposity is a risk factor for developing many cancers and 
research suggests that high levels of sedentary behavior are associated with increased adiposity. 
48, 58 Similarly, high levels of sedentary behavior are associated with increased risk of type 2 
diabetes and elevated blood glucose.48, 59 Increased levels of glucose and insulin resistance are 
hypothesized to be risk factors for some cancers. Other pathways that may be involved include 
high levels of sex hormones and inflammation, and low levels of vitamin D 93 but the evidence 
linking sedentary behavior to these pathways is very limited.93  
3.6  Summary  
Chronic diseases are the leading cause of death, premature mortality, and years lived with 
disability in the US.1, 2 Although chronic disease mortality rates have declined and life 
expectancy has increased, many adults are living longer in poor health.2  In 2010, the average US 
life expectancy at birth was 78.2 years but adults could expect to live at least 10 years with 
illness and disability.2 CVD and cancer are the major contributors to the chronic disease burden 
and the two leading causes of death.3 The major CVDs are CHD, stroke, and HF 4 and some of 
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the leading cancers are breast, prostate, lung, and colorectal.5 Two modifiable behaviors linked 
to all these diseases are physical activity and sedentary behavior. Consistent epidemiological 
evidence suggests physical activity prevents CHD, stroke, HF, postmenopausal breast cancer, 
colorectal cancer, lung cancer, and prostate cancer.6, 7 Conversely, sedentary behavior is linked to 
increased risk of these diseases.8, 9 Three studies suggest that engaging in physical activity can 
increase the number of years spent free of CVD.10-12 This research is promising for increasing 
years spent in good health but limited in a number of ways: the studies have used physical 
activity measurements that are hard to generalize across populations, have not included cancer 
outcomes, and have not examined sedentary behaviors.    
By 2030 Americans age 65 and older will account for 20% of the US population and 
currently two out of three Americans in this age group have multiple chronic conditions.72 
Identifying behaviors that can extend healthy years is a priority for older adults as this population 
is projected to grow.13 The goal of this dissertation is to fill many of the gaps in the existing 
physical activity, sedentary behavior, and health expectancy literature and to further inform how 
to increase years spent in good health.  This research set out to provide estimates of years 
expected to live free of CVD and cancer by common lifestyle behaviors by investigating the 
following aims 1) to evaluate the association of leisure-time physical activity with life 
expectancy free of disease for 3 CVDs and 4 cancers; and 2) to evaluate the association of TV 




CHAPTER 4: OVERARCHING RESEARCH METHODS 
4.1  Study population and study design 
All dissertation analyses were conducted using data from the Atherosclerosis Risk in 
Communities (ARIC) study. The ARIC study is a population-based prospective cohort of 15,792 
mostly white and African-American adults age 45 – 64 years that began in 1987 - 1989 in four 
geographic areas in the US (Forsyth County, North Carolina; Jackson, Mississippi; Washington 
County, Maryland; and Minneapolis, Minnesota). The study is ongoing and has conducted six 
examination visits (Visit 1 1987-89, Visit 2 1990-92, Visit 3 1993-95, Visit 4 1996-98, Visit 5 
2011-13, and Visit 6 2016-17).  Cohort members were asked to participate in interviews, clinical 
examinations, and annual telephone follow-up interviews.94  
All analyses used the prospective cohort design of the ARIC Study (Figure 4). Physical 
activity was measured at Visit 1 (1987-89) and Visit 3 (1993-95) and TV was measured at Visit 
1.  The following disease outcomes were ascertained from Visit 1 through 2016: CHD, stroke, 
and HF; and the cancer outcomes were ascertained from Visit 1 through 2012: postmenopausal 




Figure 4. Schematic of study design 
 
 
4.1.1 CVD analysis exclusions 
Of the 15,792 ARIC participants examined at baseline, for the CVD analysis we excluded 
participants with prevalent CVD (having prevalent CHD, stroke, or HF) (n=2,023), and 
participants who experienced a CVD event (CHD, stroke, or HF) or death within the first year of 
follow-up (n=132). Asian or American Indian/Alaskan Indian participants (n=48) and African 
American participants in Minnesota and Washington County (n=55) were excluded due to small 
numbers. After exclusions, the analytic set comprised 13,534 (86%) participants. 
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4.1.2 Cancer analysis exclusions 
Of the 15,792 ARIC participants examined at baseline, for the cancer analysis we 
excluded participants who did not consent to non-cardiovascular disease research (n=149), those 
with prevalent cancer at baseline (n=902), and those who experienced cancer (colorectal, lung, 
prostate, or breast) or death within the first year of follow-up (n=130).  We also excluded Asian 
and American Indian/Alaskan Indian participants (n=48) and African American participants in 
Minnesota and Washington County (n=55) due to small numbers at these sites. After exclusions, 
14,508 (92%) participants were included in analysis for colorectal and lung models, 6,582 men 
for prostate models and 7,849 women for postmenopausal breast models (77 women were not 
included in breast cancer models because they died or developed breast cancer before reaching 
menopause).  
4.2 Outcomes 
4.2.1 CVD outcomes 
We separately examined incident nonfatal CHD, stroke, and HF. Prevalent CHD at 
baseline was defined as a myocardial infarction (MI) from Visit 1 ECG data, or a self-reported 
history of MI or coronary revascularization. Incident nonfatal CHD was defined as definite or 
probable MI, silent MI between examinations detected by electrocardiography, and cardiac 
revascularization procedures. MI events were identified from active surveillance of 
hospitalizations occurring among ARIC cohort members.95, 96 Trained study personnel abstracted 
clinical information from the medical records of eligible hospitalizations. Definite or probable 
MI was defined from a diagnostic algorithm based on chest pain, electrocardiograms, and cardiac 
enzyme data.95 A committee reviewed all CHD events and disagreements were adjudicated.  
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Prevalent stroke at baseline was defined as self-reported history of a stroke or transient 
ischemic attack. Incident nonfatal stroke events were identified by self-report from ARIC Visit 
examinations, annual follow-up telephone calls, and active surveillance of hospitalizations in the 
ARIC communities.97 A trained nurse abstracted the medical record if a hospitalization had 
stroke diagnostic codes, if discharge summaries contained stroke related keywords, if 
neuroimaging had cerebrovascular findings, or if the patient had been admitted to the 
neurological intensive care unit.97 Stroke events were classified as definite or probable by 
computer algorithm and by a physician reviewer according to criteria adapted from the National 
Survey of Stroke.97, 98  A second physician adjudicated disagreements.  
Prevalent HF at baseline was defined as self-report of taking a medication for HF in the 
past two weeks or a score of three on the Gothenburg criteria.99  Incident nonfatal HF was 
identified by active surveillance of hospitalizations with ICD-9 code 428.xx in any position and 
relevant ICD-10 codes. Medical records of eligible hospitalizations that occurred after 2004 were 
abstracted and independently reviewed by two trained and certified physicians on the ARIC HF 
Classification Committee.100 
4.2.2 Cancer outcomes 
First primary invasive cancer diagnoses (postmenopausal breast, prostate, lung, and 
colorectal) were ascertained by linkage with statewide cancer registries from 1987 through 
December 31, 2012.101 Some of the state cancer registries were not complete or established at the 
start of the ARIC study, and for this time period cancer cases were identified by surveillance of 
hospital discharge summaries in the ARIC Study regions and confirmed with medical record 
abstraction.101 The ARIC Cancer Coordinating Center adjudication teams adjudicated all 
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potential cancer cases.101 Participants were considered to have prevalent cancer at Visit 1 if they 
been told by a doctor that they had cancer. 
4.2.3 All-cause mortality  
All-cause mortality was included as an outcome for both the CVD and cancer analyses. 
Deaths were ascertained from cohort entry until December 31, 2012 for the cancer analysis and 
until December 31, 2016 for the CVD analysis. Deaths were identified by annual phone calls, 
active surveillance of hospitalizations in ARIC communities, and linkage with the National 
Death Index. Death certificates were reviewed by medical abstractors to determine underlying 
causes of death and confirmed with family members.94, 95 
4.3. Exposures 
Leisure-time physical activity was included in both the CVD and cancer analysis. At 
Visits 1 and 3 participants were asked with the Baecke questionnaire to report up to four leisure-
time physical activities they participated in the past year.102, 103 For each activity, the number of 
hours/week (duration) and months/year (frequency) were reported and a metabolic equivalent 
(MET) value was assigned based on the Compendium of Physical Activities.104 Activities with a 
MET value of 3 or higher were classified as moderate to vigorous intensity.38 The MET, 
frequency, and duration of each activity were used to calculate MET hours per week (MET-
h/week) spent in leisure-time moderate-to-vigorous physical activity (LTPA). MET-h/week spent 
in LTPA at Visits 1 and 3 was categorized as none, < median (0.1 – <13.2 MET-h/week), and > 
median (13.2+ MET-h/week). The cut point was based on the Visit 1 median value of MET-
h/week among those who reported any LTPA.  The LTPA distribution was very similar for the 
CVD and cancer analyses and the same categories were used for both analyses. 
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Sedentary behavior, any waking behavior that expends little energy expenditure (< 1.5 
METs) while in a sitting or reclining posture,45 was assessed with a question on TV viewing. 
Participants were asked at Visit 1 how often they viewed TV and classified as never/seldom, 
sometimes, and often/very often.  TV was specified with same categories for both the CVD and 
cancer analyses 
4.4. Covariates 
In both CVD and cancer analyses, we included the following socio-demographic factors - 
age, race by ARIC study field center (white Forsyth County, African American Forsyth County, 
white Washington County, white Minneapolis, African American Jackson), gender, and 
education (high school or less, vocational school, some college or college degree, higher than 
college degree). 
Covariates used in both the CVD and cancer analyses that were assessed at all 
examination visits included smoking status (never, former, and current smoker), alcohol intake, 
and body mass index (BMI). Alcohol intake (no current intake, < 100g, and > 100g)105 was 
obtained by asking participants to report their usual intake of alcoholic beverages of a standard 
serving of wine, beer, and hard liquor per week. Weekly alcohol intake was derived as the sum 
of the alcohol amount of each type of drink (4 ounce glass of wine=10.8 grams (g), 12 ounces of 
beer=13.2g, 1.5 ounce of hard liquor=15.1g) multiplied by the number of drinks. BMI (weight in 
kilograms (kg) divided by square of height in meters (m2)) was calculated from interviewer 
measured weight and height and participants were classified according to standard BMI 
categories (underweight/normal <25.0 kg/m2, overweight 25.0 - < 30 kg/m2, and obese > 30.0 
kg/m2).106  
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For the CVD analysis, additional covariates ascertained at all examination visits included 
blood pressure, diabetes, and high density lipoprotein cholesterol (HDL-C). Seated blood 
pressure after 5 minutes of rest was measured at all visits by a trained technician. The average of 
the second and third measurement were used. Participants were classified as hypertensive if 
systolic blood pressure was >140 millimeters of mercury (mmHg), or diastolic blood pressure 
was > 90mmHg, or reported use of antihypertensive medication in the past two weeks.  Diabetes 
status was considered positive if study participants had been told by a physician they had 
diabetes, or had a fasting plasma glucose ≥126 milligrams per deciliter (mg/dL), or had a non-
fasting glucose ≥200 mg/dL, or reported use of hypoglycemic medication in the past two weeks. 
HDL-C was collected from 12 hour fasting blood samples drawn by venipuncture from an 
antecubital vein and specified as a continuous variable.  
For the cancer analysis, additional covariates included use of menopausal hormone 
therapy (MHT) and daily serving of red meat.  At each visit women self-reported use of MHT 
(never users, former users of any MHT type, current users of unopposed estrogen, current users 
of estrogen plus progestin). Habitual dietary intake was collected at Visit 1 with a modified 
version of a 66-item food frequency questionnaire.107 Participants were asked how often they ate 
a serving of a specific food item in the past year. Daily servings of red meat intake was derived 
based on how often participants reported consuming hamburgers, hot dogs, processed meats, 
bacon, and beef, pork, or lamb in the past year. 
The breast cancer analysis included only postmenopausal women. Women were 
considered postmenopausal at the ARIC visit in which they reported the following: 1) having 
both ovaries removed, or 2) if both ovaries had not been removed, they were not taking 
hormones and had not had a hysterectomy, then they were considered menopausal when they 
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reported reaching menopause or having no periods in the past two years, or 3) if both ovaries had 
not been removed but women reported taking hormones, or had a hysterectomy, or did not know 
their menopause status, then they were considered menopausal when they reached the average 
cohort race- and smoking status- specific age when menopause was reached (White- Never: 48.3, 
Former: 47.3 Current: 46.6; African American- Never: 47.8, Former: 47.0, Current: 45.6). 
4.5 Statistical analyses 
For both the CVD and cancer analyses, multistate survival models were used to estimate 
how participants moved between health (state 1), disease (state 2), and all-cause mortality (state 
3) states (Figure 5). In this model, there were three possible transitions between states– health to 
disease, health to all-cause mortality, and disease to all-cause mortality. Each type of cancer and 
CVD was considered the disease state in separate models. For each type of transition, hazard 
ratios (HR) and 95% confidence intervals (CI) were estimated with the msm R package.108, 109 
The time scale for all models was age; participants started contributing time to the study at the 
age they entered at Visit 1. For breast cancer analysis, women started contributing time at the age 
of the visit in which they were considered postmenopausal.  For the cancer analysis, follow-up 
continued until death or end of study (December 31, 2012). For the CVD analysis, follow-up 
continued until the date of last known contact with each participant, death, or end of study 
(December 31, 2016). Time-varying covariates closest in time preceding each type of transition 




Figure 5. Three state model used in analysis. 
 
We estimated life expectancy at age 50 with the Estimating Life Expectancies in 
Continuous Time (ELECT) R package separately for men and women.110 Life expectancy was 
the expected average number of remaining years of life in health and disease states conditional 
on reaching age 50 and regardless of health status at age 50.  Confidence intervals were 
estimated using 1000 bootstrap samples.  Life expectancy at age 50 was calculated separately for 
men and women at different levels of LTPA and TV viewing while specifying other covariates 
used in analytic models to the mean baseline covariate levels of the cohort.  
For both the CVD and cancer analyses, we specified models that separately examined 
LTPA and TV and then specified models that included both LTPA and TV. For all models, 
confounders included age, gender, race by ARIC center, education, smoking, and alcohol intake.  
4.6 Sensitivity analyses 
For the CVD analysis, in LTPA models that did not include TV, we also evaluated the 
impact of additional adjustment for BMI, diabetes status (yes, no), hypertension (yes, no), and 
HDL-C (continuous) in addition to previously mentioned confounders. The additional covariates 
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were limited to sensitivity analyses because they could mediate transitions between LTPA from 
health to disease, health to all-cause mortality, and disease to all-cause mortality.  
For the cancer analysis, we examined if results were sensitive to adjustment for BMI by 
adding it as a covariate to the previously described models in which LTPA and TV were 
separately examined. Further sensitivity analyses included adding MHT to the breast cancer 
LTPA model and daily serving of red meat to the colorectal LTPA model.  
4.7 Multiple imputation of missing data 
For both the CVD and cancer analyses, missing exposure and covariate data at each 
ARIC Visit were imputed with Multiple Imputation by Chained Equations (MICE).111, 112  
Multiple imputation was conducted separately for the CVD and cancer analyses. For both types 
of analyses, we imputed 10 datasets and the hazard ratios, standard errors, and life expectancy 
estimates from each dataset were averaged using Rubin’s rule.113  
Missing exposure and covariate information that occurred when participants either did 
not answer a question or did not attend an ARIC Visit was imputed with MICE. 111, 114 The 
percent of missing data ranged from 0.1% to 20% for both the CVD and cancer analysis. The 
MICE model for both types of analyses included all exposure, covariates, and outcomes used in 
analytic models, age at each visit, age at each CVD or cancer event, age at death, and 
characteristics considered to be auxiliary information.111, 112   
Variables were imputed using a regression method appropriate for their distribution. For 
both the CVD and cancer analysis, we imputed 10 datasets using a burn-in of 20 iterations before 
an imputed dataset was drawn. We examined trace plots of continuous variables and compared 
imputed and observed distributions (frequency distributions for categorical variables and kernel 
density plots for continuous variables) to assess model convergence. We also conducted a 
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validation study to measure agreement between imputed and observed values. A 20% random 
sample of participants who had non-missing exposure and covariate information at each visit 
were selected for the validation study. For these participants their observed data was set to 
missing and imputed along with the other participants. After the imputation their imputed values 
were compared to their observed data with kappa statistics and Pearson and Spearman 
correlations.   
In the CVD analysis we originally included the ARIC Visit 5 variables. The agreement 
between the imputed and observed values for the Visit 5 variables was poor and we decided to 
use variables from Visits 1 to 4 in the imputation model and analysis. In the cancer analysis we 
imputed variables for Visits 1 to 4 due to our study design (the ascertainment of cancer ends in 
2012 which is midway through Visit 5). In both the CVD and cancer validation studies, the Visit 
3 TV viewing variable did not impute well; the agreement between imputed and observed values 
was poor. Therefore, we decided to only use a baseline measure of TV viewing for both the CVD 
and cancer analyses. The validation study suggested good agreement for the other variables.  
4.8 Study power 
No methods exist to estimate power for multistate models. Therefore, we treated each 
type of transition in the multistate model (health to disease, health to death, disease to death) as a 
separate power analysis calculation.  Using the Stata Cox proportional hazard power analysis 
program, we estimated the detectable effect size (hazard ratios) for a change in a binary exposure 
variable (i.e., high physical activity vs. low, low TV viewing vs. high) at 80% power for each 
type of transition and separate for each type of disease model.  To accomplish this, we specified 
the sample size, a two-sided test, an alpha of 0.05, 80% power, and the probability of failure for 
each type of transition (Tables 7 and 8).   
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For the CVD analysis and each type of transition, the hazard ratios necessary to detect a 
change at 80% power fall well within the range of published estimates for both physical activity 
and TV viewing with incident CVD and all-cause mortality.  For the cancer analysis, the hazard 
ratios necessary to detect a minimal change for the health to disease and disease to death 
transition are stronger than that observed in most of the physical activity and TV viewing 
literature with incident cancer and survival after cancer diagnosis. For the cancer analysis, the 
range of hazard ratios for the health to death transition are within the range of published 
estimates for both the physical activity and sedentary behavior literature with all-cause mortality. 
 
Table 7. Power analysis for CVD outcomes. 







Health to disease     
CHD 13,534 2426 0.18 0.89 
Stroke 13,534 1144 0.08 0.84 
HF 13,534 2602 0.19 0.90 
Health to death    
CHD 13,534 4241 0.31 0.92 
Stroke 13,534 4741 0.35 0.92 
HF 13,534 3655 0.27 0.91 
Disease to death    
CHD 2426 1234 0.51 0.85 
Stroke 1144 734 0.64 0.81 
HF 2602 1820 0.70 0.88 
Probability of failure is calculated as number of events divided by sample size 





Table 8. Power analysis for cancer outcomes. 







Health to disease     
Colorectal 14508 361 0.025 0.75 
Lung 14508 560 0.039 0.79 
Prostate 6582 813 0.124 0.82 
Breast 7849 564 0.072 0.79 
Health to death    
Colorectal 14508 4870 0.336 0.92 
Lung 14508 4572 0.315 0.92 
Prostate 6582 2475 0.376 0.89 
Breast 7849 2041 0.260 0.88 
Disease to death    
Colorectal 361 184 0.510 0.66 
Lung 560 482 0.861 0.77 
Prostate 813 300 0.369 0.72 
Breast 564 215 0.381 0.68 




CHAPTER 5: LEISURE-TIME PHYSICAL ACTIVITY AND TELEVISION VIEWING 
WITH LIFE EXPECTANCY FREE OF NONFATAL CARDIOVASCULAR DISEASE 
5.1 Introduction 
Cardiovascular disease (CVD) is the leading cause of death, premature mortality, and 
years lived with disability.17 In the United States (US) over 92.1 million people have CVD 
(36.6%), about 16.5 million have been diagnosed with coronary heart disease (CHD), 7.2 million 
have had a stroke, and 6.5 million have been diagnosed with heart failure (HF).30 This high 
burden of CVD suggests that many years of life may be spent living with CVD. It is therefore 
important to identify opportunities to extend the number of years lived free of CVD. 
Increasingly, studies have begun using health expectancy metrics that combine incidence and 
mortality to estimate years lived with and without disease.18  
Greater amounts of physical activity have been associated with a reduced risk of CVD,6, 
115 all-cause mortality,55, 115 a longer life expectancy,55, 56 and, most recently, a longer CVD-free 
survival.10-12 Results from observational studies suggest a positive association of physical 
activity with life expectancy free of CVD.10-12 For example, in the Framingham cohort,12 men 
who self-reported high levels of physical activity based on a weighted daily sum of activities 
could expect to live 22.8 years (95% confidence interval (CI) 21.6, 23.9) CVD-free, which was 
3.2 years (95% CI 1.9, 4.3) more than men who self-reported low levels of physical activity 
(19.7 years CVD-free (95% CI 18.7, 20.6)).  Research in this area has been limited to analysis of 
one population-based cohort in the US and three cohorts in Europe. Furthermore, existing studies 
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used various methods of physical activity ascertainment making it difficult to generalize findings 
to other populations.    
Greater amounts of sedentary behavior are linked to an increased risk of incident CVD9 
and all-cause mortality.60 Sedentary behavior, any waking behavior that expends little energy 
expenditure (< 1.5 metabolic equivalent of task (MET)) while in a sitting or reclining posture,45 
is highly prevalent, as on average, Americans spend about 8 hours per day in sedentary 
behaviors.50 Little information exists on how sedentary behaviors are associated with years lived 
with and without CVD.  
Our objective was to examine the associations between physical activity and sedentary 
behavior with life expectancy with and without disease for three types of CVD: CHD, stroke, 
and HF. Gaps in the existing literature addressed by this study include the assessment of physical 
activity as MET hours per week (MET-h/week) to account for intensity of activity and to 
enhance translation of results, and the inclusion of sedentary behavior for the first time. 
5.2 Methods 
5.2.1 Study population 
We used data from the Atherosclerosis Risk in Communities (ARIC) Study. The ARIC 
Study is a population-based prospective cohort of 15,792 mostly white and African-American 
adults age 45 – 64 years at baseline. Participants were recruited from four geographic areas in the 
United States (Forsyth County, North Carolina; Jackson, Mississippi; Washington County, 
Maryland; and Minneapolis, Minnesota).94 The study has conducted six examination visits (Visit 
1 1987-89, Visit 2 1990-92, Visit 3 1993-95, Visit 4 1996-98, Visit 5 2011-13, and Visit 6 2016-
17).  Cohort members were asked to participate in interviews, clinical examinations, and annual 
(semi-annual since 2012) telephone interviews.94 Participants provided written consent at each 
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examination. The ARIC study was approved by the Institutional Review Boards of the four 
participating ARIC Study centers. 
5.2.2. Physical activity and sedentary behavior 
Physical activity was ascertained at Visits 1 and 3 with the Baecke questionnaire.102, 103  
Participants were asked to list up to four leisure-time physical activities they participated in the 
past year and to provide the number of hours/week (duration) and months/year (frequency) for 
each activity. Activities were assigned a MET value based on the Compendium of Physical 
Activities.104  Activities with a MET value of 3 or higher were classified as moderate-to-vigorous 
intensity.38 The MET, frequency, and duration of each activity were used to calculate MET-
h/week spent in leisure-time moderate-to-vigorous physical activity (LTPA). MET-h/week spent 
in LTPA at both visits was categorized as none, < median (0.1 – <13.2 MET-h/week), and > 
median (13.2+ MET-h/week). The cut point was based on the Visit 1 median value of MET-
h/week among those reporting any LTPA.  
Television (TV) viewing, an indicator of sedentary behavior, was ascertained at Visit 1 
with a question on how often participants viewed TV (response options included never, seldom, 
sometimes, often, and very often), which was further classified as never/seldom, sometimes, and 
often/very often due to small numbers in some categories.  
5.2.3 All-cause mortality 
Deaths were ascertained from cohort entry until December 31, 2016 and were identified 
by annual phone calls, active surveillance of hospitalizations in ARIC communities, and linkage 
with the National Death Index. Death certificates were reviewed by medical abstractors to 
determine underlying causes of death and the circumstances of death were confirmed with family 
members.94, 95  
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5.2.4. Cardiovascular disease outcomes 
We separately examined incident nonfatal CHD, stroke, and HF. Prevalent CHD at 
baseline was defined as a myocardial infarction (MI) from Visit 1 ECG data, or a self-reported 
history of MI or coronary revascularization. Incident nonfatal CHD was defined as definite or 
probable MI, silent MI between examinations detected by electrocardiography, and cardiac 
revascularization procedures. MI events were identified from active surveillance of 
hospitalizations occurring among ARIC cohort members.95, 96 Trained study personnel abstracted 
clinical information from the medical records of eligible hospitalizations. Definite or probable 
MI was defined from a diagnostic algorithm based on chest pain, electrocardiograms, and cardiac 
enzyme data.95 A committee reviewed all CHD events and disagreements were adjudicated.  
Prevalent stroke at baseline was defined as self-reported history of a stroke or transient 
ischemic attack. Incident nonfatal stroke events were identified by self-report from ARIC Visit 
examinations, annual follow-up telephone calls, and active surveillance of hospitalizations in the 
ARIC communities.97 A trained nurse abstracted the medical record if a hospitalization had 
stroke diagnostic codes, if discharge summaries contained stroke related keywords, if 
neuroimaging had cerebrovascular findings, or if the patient had been admitted to the 
neurological intensive care unit.97 Stroke events were classified as definite or probable by 
computer algorithm and a physician reviewer according to criteria adapted from the National 
Survey of Stroke.97, 98  A second physician adjudicated disagreements.  
Prevalent HF at baseline was defined as self-report of taking a medication for HF in the 
past two weeks or a score of three on the Gothenburg criteria.99  Incident HF was identified by 
active surveillance of hospitalizations with ICD-9 code 428.xx in any position and relevant ICD-
10 codes. Medical records of eligible hospitalizations that occurred after 2004 were abstracted 
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and independently reviewed by two trained and certified physicians on the ARIC HF 
Classification Committee.100  
5.2.5. Covariates 
Socio-demographic factors ascertained at Visit 1 and included in analyses were age, race 
by ARIC study field center (white Forsyth County, African American Forsyth County, white 
Washington County, white Minneapolis, African American Jackson), gender, and education 
(high school or less, vocational school, some college or college degree, higher than college 
degree).  
Smoking status, alcohol intake, body mass index (BMI), blood pressure, diabetes, and 
high-density lipoprotein cholesterol (HDL-C) were assessed following a standardized protocol at 
all examination visits. Smoking status was based on self-report and categorized as never, former, 
and current smokers. Alcohol intake was measured by asking participants to report their usual 
intake of alcoholic beverages of a standard serving of wine, beer, and hard liquor per week. The 
alcohol amount of each type of drink (4 ounce glass of wine=10.8 grams (g), 12 ounces of 
beer=13.2g, and 1.5 ounce of hard liquor=15.1g) was multiplied by number of drinks and 
summed for a weekly intake. Alcohol intake was further categorized as no current intake, < 
100g, and > 100g.105 
Weight and height were measured and used to calculate BMI as weight in kilograms (kg) 
divided by square of height in meters (m2) (categorized as underweight/normal <25.0 kg/m2, 
overweight 25.0 - < 30 kg/m2, and obese > 30.0 kg/m2).106 Seated blood pressure after 5 minutes 
of rest was measured at all visits by a trained technician. The average of the second and third 
measurement were used. Participants were classified as hypertensive if systolic blood pressure 
was >140 millimeters of mercury (mmHg), or diastolic blood pressure was > 90mmHg, or 
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reported use of antihypertensive medication in the past two weeks.  Diabetes status was 
considered positive if study participants had been told by a physician they had diabetes, or had a 
fasting plasma glucose ≥126 milligrams per deciliter (mg/dL), or had a non-fasting glucose ≥200 
mg/dL, or reported use of hypoglycemic medication in the past two weeks. HDL-C was collected 
from 12 hour fasting blood samples drawn by venipuncture from an antecubital vein and 
specified as a continuous variable.  
5.2.6. Statistical analysis 
Of the 15,792 ARIC participants examined at baseline, we excluded participants with 
prevalent CVD (having prevalent CHD, stroke, or HF) (n=2,023), and participants who 
experienced a CVD event (CHD, stroke, or HF) or death within the first year of follow-up 
(n=132). Asian or American Indian/Alaskan Indian participants (n=48) and African American 
participants in Minnesota and Washington County (n=55) were excluded due to small numbers. 
After exclusions, the analytic set comprised 13,534 (86%) participants.  
A non-recoverable illness-death multistate survival model was used to estimate how 
participants moved between health (state 1), disease (state 2), and all-cause mortality (state 3) 
states. In this model, participants started free of disease and moved: 1) from health to developing 
disease, or 2) from health to death from any cause. Once a participant developed disease, they 
could move from the disease state to all-cause mortality. Separate models were specified with 
different nonfatal disease states: CHD, stroke, and HF. No backward transitions were allowed 
between states. If a participant experienced a fatal disease event (date of CVD event and death 
were on the same day) they moved directly to the all-cause mortality state. In our analytic sample 
there were 282 fatal CHD events, 7 fatal stroke events, and 132 fatal HF events, in which these 
participants moved directly to the all-cause mortality state.  
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The multistate model was estimated as a Markov log-linear parametric model with an 
exponential distribution and time constant hazard using the msm R package.108, 109  Hazard ratios 
(HR) and 95% confidence intervals (CI) were estimated for each type of transition. Time-varying 
covariates closest in time preceding each transition were used for the specific transition. Age was 
used as the time scale for models; participants started contributing time to the study at the age 
they entered at Visit 1. Follow-up continued until the date of last known contact with each 
participant, death, or end of study (December 31, 2016).  
Life expectancy at age 50 (upper limit 95 years), the expected average number of 
remaining years of life in health and disease states conditional on reaching age 50, was 
calculated using the Estimating Life Expectancies in Continuous Time (ELECT) R package.110 
We estimated life expectancies at age 50 by level of LTPA and TV by examining these factors 
separately in models and then specified models that included both LTPA and TV. All models 
were adjusted for age, gender, race by ARIC center, education, smoking, and alcohol intake.  In 
LTPA models that did not include TV, we also evaluated the impact of additional adjustment for 
BMI, diabetes status (yes, no), hypertension (yes, no), and HDL-C (continuous) in addition to 
previously mentioned confounders. The additional covariates were limited to sensitivity analyses 
because they could mediate transitions between LTPA from health to disease, health to all-cause 
mortality, and disease to all-cause mortality.  
We used Multiple Imputation by Chained Equations (MICE) to impute missing exposure 
and covariate data that occurred at each visit.111, 112 We imputed 10 datasets and the multistate 
models and life expectancies were estimated in each imputed data set.  The hazard ratios, 
standard errors, and life expectancy estimates were averaged using Rubin’s rule.113   All analyses 
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were carried out with SAS Version 9.4 (Cary, North Carolina) and R Version 3.3.2 and approved 
by the Institutional Review Board of University of North Carolina at Chapel Hill.  
5.3 Results 
The average age at Visit 1 was 54 years (SD 5.7 years), 56% of participants were female, 
26% African American, and 55% had received a high school education or less (Table 9).  At 
Visit 1, almost 40% reported no LTPA; of those who reported LTPA the median was 13.2 MET 
hours per week. Close to half of all participants viewed TV sometimes (47%).  
Over a median of 27.2 years of follow-up, 4,519 (34%) participants experienced at least 
one nonfatal CVD event and 5,475 (40%) died.  The average age at incident nonfatal CHD was 
69 years (SD 8.5), 72 years (SD 8.6) at incident nonfatal stroke, and 74 years (SD 8.5) at incident 
nonfatal HF.  
5.3.1 LTPA and TV viewing with nonfatal CVD and death  
Engagement in any level of LTPA compared to none was associated with a reduced risk 
of developing nonfatal CHD, stroke, and HF (Table 10).  Participation in any LTPA compared to 
none was also associated with a lower risk of all-cause mortality in the absence of having each 
type of CVD. Participants who engaged in LTPA > median compared to none had a lower risk of 
all-cause mortality after developing nonfatal CHD. Similarly, for nonfatal HF, engagement in 
any level of LTPA compared to none was associated with lower risk of all-cause mortality after 
developing nonfatal HF. Results were not sensitive to controlling for additional factors (BMI, 
hypertension, diabetes, HDL-C) that may act as mediators or confounders.  
Watching TV seldom/never compared to viewing TV often/very often was associated 
with a reduced risk of nonfatal CHD and HF, but was not associated with nonfatal stroke (Table 
11). Across all diseases, watching TV sometimes or seldom/never was associated with a lower 
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risk of all-cause mortality in the absence of having each type of CVD. The associations of TV 
viewing with all-cause mortality after developing each disease were close to the null.  
The hazard ratios from models that included both LTPA and TV were similar to the 
models that separately examined these factors.  
5.3.2 LTPA with nonfatal CHD, stroke, and HF life expectancy 
Engagement in any LTPA compared to none was associated in a positive dose response 
fashion with a longer nonfatal disease-free life expectancy for each type of CVD (Figure 6). At 
LTPA levels < median, life expectancy disease-free was ~ 0.8 years longer compared to no 
LTPA for each type of nonfatal CVD. At LTPA > median, compared to no LTPA, disease-free 
life expectancy was ~1.5 years longer (CHD: men 1.5 years (95% CI 1.0, 2.0), women 1.6 years 
(95% CI 1.1, 2.2), stroke: men 1.8 years (95% CI 1.2, 2.3), women 1.8 years (95% CI 1.3, 2.3), 
HF: men 1.6 years (95% CI 1.1, 2.1), women 1.7 years (95% CI 1.2, 2.2)). For each type of 
CVD, life expectancy with disease was similar for three levels of LTPA. 
 5.3.3 TV with nonfatal CHD, stroke, and HF life expectancy 
Watching TV sometimes or seldom/never was associated with longer disease-free life 
expectancy compared to often/very often viewing (Figure 7). For example, compared to 
participants who often/very often viewed TV, participants who seldom/never watched had a 
longer nonfatal CHD-free life expectancy (men 1.1 years (95% CI 0.5, 1.7), women 0.9 years 
(95% CI 0.3, 1.6)), greater nonfatal stroke-free life expectancy (men 0.8 years (95% CI 0.2, 1.4), 
women 0.8 years (95% CI 0.2, 1.4)), and greater nonfatal HF-free life expectancy (men 0.9 years 
(95% CI 0.3, 1.5), women 1.0 years (95% CI 0.4, 1.6)). Across all diseases, the life expectancy 
disease-free was similar for the sometimes and seldom/never viewing TV levels. For each type 
of CVD, the life expectancy with nonfatal disease was similar by level of TV viewing.   
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5.3.4 Models with both LTPA and TV with nonfatal CHD, stroke, and HF life expectancy 
Across all diseases, participants who engaged in LTPA > median and seldom/never 
viewing TV had ~2.5 year greater nonfatal disease-free life expectancy compared to participants 
who reported no LTPA and often/very often watching TV (Figure 8) (CHD: men 2.4 years (95% 
CI 1.7, 3.2), women 2.4 years (95% CI 1.7, 3.2); stroke: men 2.4 years (95% CI 1.6, 3.1), women 
2.4 years (95% CI 1.7, 3.2), HF: men 2.4 years (95% CI 1.7, 3.1), women 2.5 years (95% CI 1.8, 
3.2)).   
5.4 Discussion 
In this large prospective cohort of adults, engagement in any level of LTPA was 
associated with longer nonfatal CVD-free life expectancy when compared to engaging in no 
LTPA. Such associations were observed for nonfatal CHD, stroke, and HF. The inverse 
association of TV viewing with CVD-free life expectancy outcomes was of modest magnitude, 
with a small gain in CVD-free life expectancy for viewing TV sometimes and seldom/never 
compared to often/very often TV viewing.  
The observed pattern of an extended disease-free life expectancy with higher LTPA 
levels is consistent with published reports.10-12  In reports from the Framingham cohort, 
participants who self-reported high as compared to low levels of physical activity, had CVD-free 
life expectancy that was longer by about three years.11, 12 However, it is difficult to compare our 
MET-h/week of LTPA with the physical activity measurement used in the Framingham cohort, 
which was estimated as a weighted sum of daily activities based on sleeping, resting, and 
engaging in light, moderate, or heavy activity.12  O’Doherty et al.10 separately analyzed data 
from three European-based cohorts and observed that participation in vigorous activity compared 
to no vigorous physical activity was associated with a longer CVD-free life expectancy 
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(estimates ranged from three to five years).  Although we found similar trends in LTPA 
extending years spent free of CVD, the magnitude of our findings was smaller compared to these 
other studies. These differences may be due to characteristics of each cohort, the various 
methods of physical activity measurement, and different analytic methods and covariates used.  
Our report extends the understanding of how physical activity is associated with CVD 
life expectancy outcomes by measuring LTPA as MET-h/week to account for intensity of 
activity and separately examining three types of CVD. We observed a positive dose-response 
relationship between LTPA and nonfatal disease-free life expectancy. At LTPA < median, 
nonfatal disease-free life expectancy was longer by more than half a year for each type of CVD 
compared to no LTPA. At LTPA > median, we observed close to two years longer nonfatal 
disease-free life expectancy compared to no LTPA. For reference, a person who engages in a 
walk at 3 miles per hour, estimated to be 3.3 METs, for five days of the week, at 50 minutes per 
day can expend 13.8 MET-h/week.   
We separately examined three types of nonfatal CVD and observed homogeneity of 
associations of LTPA with nonfatal CHD, stroke, and HF. The hazard ratios we estimated for 
how LTPA was associated with nonfatal incident CHD, stroke, and HF are consistent with 
existing research in regards to the direction and magnitude of estimates when physical activity 
has been specified as MET-h/week.6  The similarities of associations of LTPA with these three 
CVDs may be because physical activity has been linked to reduced adiposity, improved blood 
pressure, prevention of diabetes, and improvement in lipid profiles, factors that are all risk 
factors for CHD, stroke, and HF.31  
Our study is the first, to our knowledge, to examine how sedentary behavior is associated 
with nonfatal CVD life expectancy outcomes. We observed a gain in nonfatal disease-free life 
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expectancy of approximately one year for sometimes and seldom/never viewing TV compared to 
often/very often viewers, but the estimates for the sometimes and seldom/never TV viewers were 
similar with overlapping confidence intervals.  Our associations of hazard ratios of TV viewing 
with incident nonfatal CVD and all-cause mortality are in the same direction as existing literature 
but are somewhat weaker.61, 62 Often TV viewing is measured as hours per week spent viewing 
and studies using this type of measure have estimated a higher risk of incident CVD at two hours 
of viewing per day or higher, and a higher risk of all-cause mortality at three and four hours per 
day of viewing.61, 62 A limitation of our study is that it did not assess the number of hours spent 
watching TV.  
We analyzed each type of nonfatal CVD separately, but observed that 32% participants 
who developed CVD did experience multiple CVD events. In additional analysis we estimated 
life expectancy at age 50 for a composite CVD outcome that was the first occurrence of nonfatal 
CHD, stroke, or HF. The life expectancy differences by LTPA and TV with the composite CVD 
outcome were similar to associations observed when examining each disease individually. 
However, nonfatal life expectancy CVD-free was lower and life expectancy with nonfatal CVD 
was higher than the respective life expectancy estimates when separately examining each 
disease.  
To estimate life expectancy CVD-free we used a health expectancy outcome, a summary 
measure that estimates expected years to live in good and poor health. Improving and 
maintaining the health of older adults is a priority, as this population is projected to grow and 
chronic diseases often develop at older ages.13  Other strengths of this study include use of time-
varying covariates, well-measured outcomes from active surveillance and adjudication of 
outcomes, long-term follow-up of over 30 years, and multiple imputation of exposure and 
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covariate data. Although we included time-varying measurements of physical activity, we did not 
have a physical activity measurement after Visit 3 and we used a baseline measure of TV 
viewing. It is possible participant levels for both types of behaviors changed after the last 
measurement of each.  
Limitations of this report include the self-reported nature of LTPA and extent of TV 
viewing, and having a single domain of physical activity and sedentary behavior. Levels of 
physical activity tend to be overestimated when collected by self-report; however, the Baecke 
questionnaire is similar in reliability and validity to other physical activity questionnaires.116, 117 
We included physical activity during leisure-time and did not include activity that takes place 
during occupation, transport, or housework activities. It is possible our associations could be 
stronger with the inclusion of physical activity that occurs from multiple domains. TV viewing 
represents only one domain of sedentary behavior and does not include time spent sitting for 
work or transport.  
5.5. Conclusion 
Engagement in any level of LTPA and viewing TV sometimes or seldom/never were 
associated with longer life expectancy free of nonfatal CHD, stroke, and HF. Our findings 
suggest that engaging in LTPA and watching less TV could increase the number of years lived 








Table 9. Visit 1 characteristics of ARIC Study participants by LTPA and TV viewing (n=13,534). 
  Leisure-time physical activity   TV viewing   Overall  




Sometimes Often/ very 
often 
  
  N=5114 N=4207 N=4207 
 
N=2601 N=6393 N=4528 
 
N=13,534 
Age at V1, mean(SD) 54.3 (5.7) 54.4 (5.7) 54.5 (5.8) 
 
53.9 (5.7) 54.4 (5.7) 54.7 (5.8) 
 
54.4 (5.7) 
Male, % 2045 (40.0) 1643 (39.1) 2222 (52.8) 
 
1027 (39.5) 2650 (41.5) 2231 (49.3) 
 
5915 (43.7) 
ARIC center, n(%) 
         
Forsyth County 1111 (21.7) 1148 (27.3) 1225 (29.1) 
 
694 (26.7) 1681 (26.3) 1107 (24.5) 
 
3485 (25.8) 
Jackson 1893 (37.0) 722 (17.2) 552 (13.1) 
 
370 (14.2) 1484 (23.2) 1313 (29.0) 
 
3171 (23.4) 
Minneapolis 915 (17.9) 1255 (29.8) 1406 (33.4) 
 
866 (33.3) 1636 (25.6) 1074 (23.7) 
 
3576 (26.4) 
Washington County 1195 (23.4) 1082 (25.7) 1024 (24.3) 
 
671 (25.8) 1592 (24.9) 1034 (22.8) 
 
3302 (24.4) 
White race/ethnicity, n(%) 3076 (60.2) 3333 (79.2) 3566 (84.8) 
 
2190 (84.2) 4773 (74.7) 3006 (66.4) 
 
9977 (73.7) 
African American  
race/ethnicity, n(%) 
2038 (39.9) 874 (20.8) 641 (15.2) 
 




         
high school or less 3355 (65.7) 2234 (53.2) 1808 (43.0) 
 
1230 (47.3) 3436 (53.8) 2726 (60.3) 
 
7403 (54.8) 
vocational 386 (7.6) 387 (9.2) 365 (8.7) 
 
208 (8.0) 551 (8.6) 378 (8.4) 
 
1138 (8.4) 
college 987 (19.3) 1168 (27.8) 1398 (33.3) 
 
821 (31.6) 1702 (26.7) 1030 (22.8) 
 
3553 (26.3) 
graduate/professional 376 (7.4) 414 (9.9) 632 (15.0) 
 
339 (13.1) 695 (10.9) 388 (8.6) 
 
1422 (10.5) 
Missing 10 4 4 
 
3 9 6 
 
18 
Leisure-time physical activity, n(%) 
        
no LTPA 
    




    




    




    
0 0 0 
 
6 
TV viewing, n(%) 
         
seldom/never 807 (15.8) 791 (18.8) 1003 (23.9) 
     
2601 (19.2) 
sometimes 2408 (47.1) 1941 (46.2) 2044 (48.6) 
     
6393 (47.3) 
often/very often 1897 (37.1) 1473 (35.0) 1158 (27.5) 
     
4528 (33.5) 
Missing 2 2 2 
     
12 
Smoking, n(%) 
         
current smoker 1616 (31.6) 994 (23.6) 833 (19.8) 
 
521 (20.1) 1540 (24.1) 1381 (30.5) 
 
3446 (25.5) 
past smoker 1347 (26.4) 1311 (31.2) 1584 (37.7) 
 
836 (32.2) 1971 (30.8) 1435 (31.7) 
 
4244 (31.4) 
never smoker 2147 (42.0) 1900 (45.2) 1788 (42.5) 
 
1242 (47.8) 2880 (45.1) 1708 (37.8) 
 
5836 (43.2) 
Missing 4 2 2 
 
2 2 4 
 
8 
Alcohol intake, n(%) 
         
not current drinker 3419 (67.4) 2543 (60.7) 2185 (52.2) 
 
1586 (61.2) 3886 (61.1) 2669 (59.3) 
 
8150 (60.5) 
< 100 grams 1020 (20.1) 1114 (26.6) 1303 (31.1) 
 







  Leisure-time physical activity   TV viewing   Overall  




Sometimes Often/ very 
often 
  
  N=5114 N=4207 N=4207 
 
N=2601 N=6393 N=4528 
 
N=13,534 
> 100 grams 637 (12.6) 535 (12.8) 701 (16.7) 
 
333 (12.9) 842 (13.2) 698 (15.5) 
 
1875 (13.9) 
Missing 38 15 18 
 
11 30 30 
 
72 
BMI, mean (SD) 28.5 (5.8) 27.2 (5.0) 26.7 (4.5) 
 
26.7 (4.9) 27.5 (5.2) 28.0 (5.4) 
 
27.5 (5.2) 
Missing 5 2 1 
 
2 1 5 
 
8 
Have hypertension, n(%) 1917 (37.5) 1230 (29.3) 1087 (25.9) 
 
652 (25.1) 1971 (30.9) 1611 (35.6) 
 
4237 (31.3) 
Missing 7 5 2 
 
0 9 4 
 
14 
Have diabetes, n(%) 649 (12.9) 395 (9.4) 332 (7.9) 
 
202 (7.8) 631 (10.0) 542 (12.1) 
 
1377 (10.3) 
Missing 64 20 24 
 
14 52 42 
 
108 
HDL-C, mean(SD) 51.8 (17.0) 52.6 (16.7) 52.6 (17.3) 
 
54.4 (17.6) 52.5 (16.7) 50.9 (17.0) 
 
52.3 (17.0) 
Missing 119 39 31   23 94 72   189 
Abbreviations: BMI= body mass index, HDL-C high density lipoprotein cholesterol, LTPA= leisure-time moderate-to-vigorous physical activity, 
MET= metabolic equivalent of task  




Table 10. Associations (hazard ratios (95% CI)) of LTPA with nonfatal CHD, stroke, HF, 
and all-cause mortality, ARIC participants (n=13,534). 
  health to disease health to death disease to death 
  HR (95% CI) 
Nonfatal CHD    
    Number of events 2,426 4,241 1,234 
    Sum of person-years 292,957 292,957 23,887 
LTPA    
    No LTPA ref ref ref 
    < median 0.92(0.82,1.02) 0.91(0.84,0.99) 0.98(0.84,1.13) 
    > median 0.88(0.79,0.97) 0.80(0.74,0.87) 0.83(0.72,0.96) 
Nonfatal Stroke    
    Number of events 1,144 4,741 734 
    Sum of person-years 309,746 309,746 7,099 
LTPA    
    No LTPA ref ref ref 
    < median 0.86(0.74,1.00) 0.92(0.85,0.99) 1.06(0.88,1.28) 
    > median 0.80(0.68,0.92) 0.80(0.74,0.86) 1.01(0.83,1.23) 
Nonfatal HF    
    Number of events 2,602 3,655 1,820 
    Sum of person-years 304,313 304,313 12,531 
LTPA    
    No LTPA ref ref ref 
    < median 0.87(0.79,0.95) 0.94(0.87,1.02) 0.88(0.79,0.99) 
    > median 0.80(0.72,0.88) 0.82(0.76,0.89) 0.82(0.73,0.92) 
LTPA categories: < median (0.1 - < 13.2 MET-h/week), > median (13.2+ MET-h/week) 
Models specified separately for each type of disease state. Models adjusted for age, gender, race by ARIC center, 
education, smoking, and alcohol intake. Abbreviations: CI= confidence interval, CHD= coronary heart disease, HF= 
heart failure, HR= hazard ratio, LTPA=leisure-time moderate-to-vigorous physical activity, MET= metabolic 






Table 11. Associations (hazard ratio (95% CI)) of TV viewing with nonfatal CHD, stroke, 
HF, and all-cause mortality, ARIC participants (n=13,534). 
  health to disease health to death disease to death 
  HR (95% CI) 
Nonfatal CHD    
    Number of events 2,426 4,241 1,234 
    Sum of person-years 292,957 292,957 23,887 
TV viewing    
    Often/very often ref ref ref 
    Sometimes 0.98(0.89,1.07) 0.92(0.86,0.99) 0.89(0.79,1.01) 
    Seldom/never 0.83(0.74,0.94) 0.91(0.84,1.00) 0.93(0.79,1.11) 
Nonfatal Stroke    
    Number of events 1,144 4,741 734 
    Sum of person-years 309,746 309,746 7,099 
TV viewing    
    Often/very often ref ref ref 
    Sometimes 0.98(0.86,1.12) 0.90(0.85,0.96) 1.04(0.89,1.22) 
    Seldom/never 0.98(0.82,1.17) 0.89(0.82,0.97) 0.95(0.76,1.19) 
Nonfatal HF    
   Number of events 2,602 3,655 1,820 
   Sum of person-years 304,313 304,313 12,531 
TV viewing    
   Often/very often ref ref ref 
   Sometimes 0.81(0.74,0.88) 0.97(0.90,1.04) 0.97(0.87,1.07) 
   Seldom/never 0.87(0.78,0.97) 0.91(0.82,1.00) 1.02(0.89,1.17) 
Models specified separately for each type of disease state. Models adjusted for age, gender, race by ARIC center, 
education, smoking, and alcohol intake. Abbreviations: CI= confidence interval, CHD= coronary heart disease, HF= 






Figure 6. Life expectancy (years) free of nonfatal cardiovascular disease and life 




LTPA categories: < median (0.1 - < 13.2 MET-h/week), > median (13.2+ MET-h/week) 
All disease states are nonfatal. Models specified separately for each type of disease state. Models adjusted for age, 
gender, race by ARIC center, education, smoking status, and alcohol intake. Abbreviations: CHD= coronary heart 
disease, CI = confidence interval, HF= heart failure, LE= life expectancy, LTPA=leisure-time moderate-to-vigorous 




Figure 7. Life expectancy (years) free of nonfatal cardiovascular disease and life 




All disease states are nonfatal. Models specified separately for each type of disease state. Models adjusted for age, 
gender, race by ARIC center, education, smoking status, and alcohol intake. Abbreviations: CHD = coronary heart 





Figure 8. Life expectancy (years) free of nonfatal cardiovascular disease and life 
expectancy differences at age 50 by LTPA and TV viewing, ARIC participants (n=13,534).  
 
a) nonfatal CHD 
 








3c) nonfatal HF 
 
 
LTPA categories: < median (0.1 - < 13.2 MET-h/week), > median (13.2+ MET-h/week) 
TV categories: high TV is viewing often/very often, some TV is sometimes viewing, and low TV is seldom/never 
viewing TV. Models specified separately for each type of disease state. Models adjusted for age, gender, race by 
ARIC center, education, smoking status, and alcohol intake. Abbreviations: CI = confidence interval, LE= life 






CHAPTER 6: LEISURE-TIME PHYSICAL ACTIVITY AND TELEVISION VIEWING 
WITH LIFE EXPECTANCY FREE OF CANCER 
6.1 Introduction 
Cancer contributes significantly to years lived with disability and to the risk of 
mortality.118 In the United States (US), 15.5 million men and women have a personal cancer 
history32 and by 2020 this number is expected to increase to 18 million.119 Prostate, breast, lung 
and bronchus, and colorectal cancer account for 46% of newly diagnosed invasive cancers 
among men and women.32 The number of years lived without cancer can be estimated with 
health expectancy outcomes, a measure that combines incidence and mortality to divide life 
expectancy into life expectancy with and without disease.18  
Physical activity has been associated with a reduced risk of many types of cancer,7 longer 
survival after cancer diagnosis,120 and longer life expectancy.55 Recent studies on physical 
activity and health expectancy outcomes have observed that greater amounts of physical activity 
were associated with longer disease-free life expectancy from cardiovascular disease (CVD),10, 12 
diabetes,25 and chronic disease (a composite measure of CVD, diabetes, and cancer)28 but no 
studies have separately examined specific cancer types. Sedentary behavior, conversely, has been 
associated with an increased risk of incident cancer8 and all-cause mortality.60 To date, sedentary 
behavior has not been examined in relation to cancer health expectancy outcomes.  
We sought to understand how physical activity and sedentary behavior were associated 
with cancer health expectancy outcomes, with particular focus on life expectancy cancer-free. 
Therefore, we examined how physical activity and television (TV) viewing, a common type of 
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sedentary behavior, were associated with life expectancy free of four leading types of cancer - 
colorectal, lung, prostate, and postmenopausal breast cancer, in a population-based cohort of 
adults from the Atherosclerosis Risk in Communities (ARIC) Study.  
6.2 Methods 
6.2.1 Study population 
We used data from the ARIC Study, a prospective cohort of 15,792 mostly white and 
African-American adults. Participants, age 45 – 64 years at Visit 1, were enrolled from four 
geographic areas in the US (Forsyth County, North Carolina; Jackson, Mississippi; Washington 
County, Maryland; and Minneapolis, Minnesota). Six examination visits have been conducted 
(Visit 1 1987-89, Visit 2 1990-92, Visit 3 1993-95, Visit 4 1996-98, Visit 5 2011-13, and Visit 6 
2016-17).  Cohort members were asked to participate in interviews, clinical examinations, and 
annual (semi-annual from 2012) telephone follow-up interviews.94 All participants provided 
informed consent at each study visit. The ARIC study was approved by the Institutional Review 
Boards of the four participating ARIC Study centers. 
6.2.2 Physical activity and sedentary behavior 
At Visits 1 and 3 participants were asked to complete the Baecke questionnaire and list 
up to four leisure-time physical activities they participated in during the past year.102, 103  For 
each activity, the number of hours/week (duration) and months/year (frequency) were reported 
and a metabolic equivalent of task (MET) value was assigned based on the Compendium of 
Physical Activities.104 Activities with a MET value of 3 or higher were classified as moderate to 
vigorous intensity.38 The MET, frequency, and duration of each activity were used to calculate 
MET hours per week (MET-h/week) spent in leisure-time moderate-to-vigorous physical activity 
(LTPA). MET-h/week spent in LTPA at Visits 1 and 3 was categorized as none, < median (0.1 – 
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<13.2 MET-h/week), and > median (13.2+ MET-h/week). The cut point was based on the Visit 1 
median value of MET-h/week among those reporting any LTPA.  
Sedentary behavior, any waking behavior that expends little energy expenditure (< 1.5 
MET) while in a sitting or reclining posture,45 was assessed with a question on TV viewing. 
Participants were asked at Visit 1 how often they viewed TV (never, seldom, sometimes, often, 
very often) and classified as never/seldom, sometimes, and often/very often due to small 
numbers in some categories.  
6.2.3 Cancer and all-cause mortality outcomes 
First primary invasive cancer diagnoses (postmenopausal breast, prostate, lung, and 
colorectal) were ascertained by linkage with statewide cancer registries from 1987 through 
December 31, 2012.101 Some of the state cancer registries were not complete or established at the 
start of the ARIC study, and for this time period, cancer cases were identified by surveillance of 
hospital discharge summaries in the ARIC Study regions and confirmed with medical record 
abstraction.101 The ARIC Cancer Coordinating Center adjudication teams adjudicated all 
potential cancer cases.101 Participants were considered to have prevalent cancer at Visit 1 if a 
doctor had told them that they had cancer.  
Deaths were ascertained from Visit 1 until December 31, 2012 through active 
surveillance of vital status and by linkage with the National Death Index. Medical records were 
abstracted and circumstances of the death confirmed with family members.94, 95 
6.2.4 Covariate assessment 
We included the following socio-demographic factors as covariates: age (continuous), 
race by ARIC center (white Forsyth County, African American Forsyth County, white 
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Washington County, white Minneapolis, African American Jackson), gender, and education 
(<high school, vocational school, some college/college degree, graduate/professional). 
Time updated covariates collected at all examination visits were smoking status (never, 
former, current smoker), alcohol intake, body mass index (BMI), and use of menopausal 
hormone therapy (MHT). Alcohol intake (no current intake, < 100g, > 100g)105 was obtained by 
asking participants to report their usual intake of alcoholic beverages of a standard serving of 
wine, beer, and hard liquor per week. Weekly alcohol intake was derived as the sum of the 
alcohol amount of each type of drink (4 ounce glass of wine=10.8 grams (g), 12 ounces of 
beer=13.2g, 1.5 ounce of hard liquor=15.1g) multiplied by the number of drinks. BMI (weight in 
kilograms (kg) divided by square of height in meters (m2)) was calculated from interviewer 
measured weight and height and participants were classified according to standard BMI 
categories (underweight/normal <25.0 kg/m2, overweight 25.0 - < 30 kg/m2, obese > 30.0 
kg/m2).106 At each visit women self-reported use of MHT (never users, former users of any MHT 
type, current users of unopposed estrogen, current users of estrogen plus progestin). 
Food consumption was collected at Visit 1 with a modified version of a 66-item food 
frequency questionnaire.107 Daily servings of red meat intake was derived based on how often 
participants reported consuming hamburgers, hot dogs, processed meats, bacon, and beef, pork, 
or lamb in the past year. 
Women were considered postmenopausal at the ARIC Visit in which they reported the 
following: 1) having both ovaries removed, or 2) if both ovaries had not been removed, they 
were not taking hormones and had not had a hysterectomy, then they were considered 
menopausal when they reported reaching menopause or having no periods in the past two years, 
or 3) if both ovaries had not been removed but women reported taking hormones, or had a 
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hysterectomy, or did not know their menopause status, then they were considered menopausal 
when they reached the average cohort race- and smoking status- specific age when menopause 
was reached (White- Never: 48.3, Former: 47.3 Current: 46.6; African American- Never: 47.8, 
Former: 47.0, Current: 45.6).  
6.2.5 Statistical analysis 
Of the 15,792 ARIC participants examined at baseline, we excluded participants who did 
not consent to non-cardiovascular disease research (n=149) and those with prevalent cancer at 
baseline (n=902). We excluded participants who experienced cancer (colorectal, lung, prostate, 
or breast) or death within the first year of follow-up (n=130) to establish temporality between 
physical activity and TV viewing with cancer and mortality outcomes.  We also excluded Asian 
and American Indian/Alaskan Indian participants (n=48) and African American participants in 
Minnesota and Washington County (n=55) due to small numbers at these sites. After exclusions, 
14,508 (92%) participants were included in analysis for colorectal and lung models, 6,582 men 
for prostate models and 7,849 women for postmenopausal breast models (77 women were not 
included in breast cancer models because they died or developed breast cancer before reaching 
menopause).  
We used multistate survival models to estimate how participants moved between health 
(state 1), disease (state 2), and all-cause mortality (state 3) states. This model had three possible 
transitions – health to disease, health to all-cause mortality, and disease to all-cause mortality. 
Each type of cancer was the disease state in separate models. For each type of transition, hazard 
ratios (HR) and 95% confidence intervals (CI) were estimated with the msm R package.108, 109 
The time scale for all models was age; participants started contributing time to the study at the 
age they entered at Visit 1. For breast cancer analyses, women started contributing time at the 
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age of the visit in which they were considered postmenopausal.  Follow-up continued until death 
or end of study (December 31, 2012). Time-varying covariates closest in time preceding each 
type of transition were used for the specific transition.  
We estimated life expectancy at age 50 with the Estimating Life Expectancies in 
Continuous Time (ELECT) R package separately for men and women.110 Life expectancy was 
defined as the expected average number of remaining years of life in health and disease states 
conditional on reaching age 50 and regardless of health status at age 50. We estimated life 
expectancy by level of LTPA and TV viewing. First we specified models that separately 
examined LTPA and TV and then specified models that included both LTPA and TV. For all 
models, confounders included age, gender, race by ARIC center, education, smoking, and 
alcohol intake.  
We examined if results were sensitive to adjustment for BMI by adding it as a covariate 
to the models in which LTPA and TV were separately examined. Further sensitivity analyses 
included adding MHT to the breast cancer LTPA model and daily servings of red meat to the 
colorectal LTPA model, both potential cancer-specific confounders.  
Missing exposure and covariate data that occurred at each visit were imputed with 
Multiple Imputation by Chained Equations (MICE).111, 112  We imputed 10 datasets and the 
hazard ratios, standard errors, and life expectancy estimates from each dataset were averaged 
using Rubin’s rule.113 All analyses were carried out with SAS Version 9.4 (Cary, North Carolina) 
and R Version 3.3.2. Analyses were approved by the Institutional Review Board at the 




At baseline, the average age of participants was 54 years (SD 5.7), 55% were female, 
28% were African American, 56% had a high school education or less, and most participants 
were not current smokers or current drinkers (Table 12). Over 60% of participants reported any 
LTPA and 47% reported watching TV sometimes.  Ninety percent of women were 
postmenopausal at Visit 1 and the average daily red meat intake was 1.1 servings.  
Over a median 23.6 years of follow-up, 2,360 (16.3%) participants had a diagnosis of 
incident invasive first primary colorectal, lung, prostate, or postmenopausal breast cancer and 
5,054 (34.8%) deaths occurred in the full cohort. The average age at cancer diagnosis was 68.8 
years (SD 7.5) for colorectal, 69.7 years (SD 7.3) for lung, 68.6 years (SD 6.3) for prostate, and 
66.7 years (SD 7.3) for postmenopausal breast cancer.  
6.3.1 LTPA and TV viewing with cancer and all-cause mortality 
Compared to no LTPA, engagement in any LTPA was associated with a lower risk of 
lung cancer, and at LTPA > median, a lower risk of colorectal and breast cancer (Table 13).  
Across all models, engagement in LTPA showed an inverse dose-response relationship with all-
cause mortality in the absence of cancer.  Participants who engaged in any level of LTPA had a 
lower risk of all-cause mortality following a breast cancer diagnosis.   In sensitivity analysis, we 
added BMI to these models and observed similar hazard ratios.  Results were similarly robust to 
the addition of MHT to the breast cancer model and daily red meat servings to the colorectal 
cancer model. 
Level of TV viewing was not associated with incidence of cancer, of any type (Table 14). 
Watching TV sometimes or seldom/never compared to often/very often was associated with a 
lower risk of all-cause mortality in the absence of cancer. TV viewing was not associated with 
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all-cause mortality after developing cancer. We added BMI to these models and observed similar 
hazard ratios.  
In models that mutually adjusted for both LTPA and TV, the hazard ratios were similar to 
when LTPA and TV were separately examined. 
6.3.2 LTPA with colorectal, lung, prostate, and postmenopausal breast cancer life 
expectancy 
For each cancer type, engagement in LTPA showed a positive dose-response relationship 
with greater cancer-free life expectancy.  For example, for colorectal, lung, and breast cancer, 
participants who engaged in LTPA < median had ~1 year greater cancer-free life expectancy 
compared to participants who reported no LTPA. At LTPA > median compared to none, 
participants had a greater cancer-free life expectancy of over 2 years for colorectal (men 2.2 
years (95% CI 1.7, 2.7), women 2.3 years (95% CI 1.7, 2.8)), lung (men 2.1 years (95% CI 1.5, 
2.6), women 2.1 years (95% CI 1.6, 2.7)), and breast cancer (2.4 years (95% CI 1.4, 3.3)), and 
over 1 year for prostate cancer (1.5 years (95% CI 0.8, 2.2)) (Figure 9). Life expectancy with 
cancer was similar by level of LTPA for colorectal and lung cancer.  For prostate and breast 
cancer, life expectancy with cancer was longer at LTPA levels < median and > median compared 
to no LTPA, although the confidence intervals for life expectancy with cancer at each level of 
LTPA overlapped. 
6.3.3 TV viewing with colorectal, lung, prostate, and postmenopausal breast cancer life 
expectancy 
Life expectancy cancer-free was longer for viewing TV sometimes and seldom/never 
compared to often/very often viewing TV for colorectal, lung, and breast cancer (Figure 10). 
Compared to often/very often viewing TV, viewing TV seldom/never was associated with a 
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greater cancer-free life expectancy of ~1 year for colorectal (men 1.2 years (95% CI 0.5, 1.9), 
women 1.2 years (95% CI 0.6, 1.9)), lung (men 1.4 years (95% CI 0.7, 2.0), women 1.4 years 
(95% CI 0.7, 2.1)), and breast cancer (women 1.4 years (95% CI 0.4, 2.4)) (Figure 10). However, 
for prostate cancer, seldom/never watching TV compared to often/very often was not associated 
with longer cancer-free life expectancy (0.5 years (95% CI -0.4, 1.3).  Life expectancy with 
cancer was similar for each level of TV viewing for colorectal, lung, and breast cancer. For 
prostate cancer, life expectancy with cancer was longer for sometimes and seldom/never viewing 
TV compared to often/very often but the confidence intervals for life expectancy with cancer at 
each level of TV viewing overlapped. 
6.3.4 Combined LTPA and TV viewing with colorectal, lung, prostate, and postmenopausal 
breast cancer life expectancy 
For all types of cancer, participating in more LTPA and viewing less TV were associated 
in a dose-response fashion with life expectancy cancer-free (Figure 11).  For colorectal, lung, 
and breast cancer, life expectancy cancer-free was greater by ~3 years for engaging in LTPA > 
median and seldom/never viewing TV compared to the referent group of no LTPA and 
often/very often viewing TV (colorectal: men 3.2 years (95% CI 2.4, 4.0), women 3.3 years 
(95% CI 2.4, 4.1), lung: men 3.3 years (95% CI 2.5, 4.1), women 3.4 years (95% CI 2.5, 4.2), 
breast: 3.5 years (95% CI 2.2, 4.8)). This association was attenuated for prostate cancer with a 
life expectancy difference cancer-free of 2 years for LTPA > median and seldom/never viewing 
TV compared to the referent group (1.9 years (95% CI 0.9, 3.0)).  
6.4 Discussion 
In this population-based cohort, engagement in any LTPA and viewing TV sometimes or 
seldom/never were associated with extended cancer-free life expectancy. Engagement in LTPA 
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showed a positive dose-response relationship with cancer-free life expectancy, such that at each 
level of LTPA participation life expectancy cancer-free was greater by approximately one year. 
Viewing TV sometimes or seldom/never was associated with a longer cancer-free life 
expectancy, but the magnitude of associations was more modest than those observed for LTPA. 
Cancer-free life expectancy findings were consistent for colorectal, lung, and breast cancer but 
weaker results were found with prostate cancer. 
Engagement in more LTPA was associated with a lower incidence of colorectal, lung, 
and breast cancer but not prostate cancer. Our results on LTPA and cancer incidence are 
consistent with existing studies that have reported inverse associations with incident colorectal, 
lung, and breast cancer and mixed results for prostate cancer.7, 74, 76, 78, 80 Our results also support 
the inverse association between greater LTPA and a reduced risk of all-cause mortality that has 
been reported by other cohort studies.55, 115  Plausible biological mechanisms for how physical 
activity may reduce the risk of multiple cancers include reducing levels of adiposity, decreasing 
levels of sex and metabolic hormones, reducing systemic inflammation, improving immune 
function, and for colorectal cancer, improving colon motility.91  
We observed a positive, graded relationship between LTPA and cancer-free life 
expectancy for all four types of cancer.  For colorectal, lung, and breast cancer, at LTPA < 
median, life expectancy cancer-free was approximately 1 year greater, compared to no LTPA 
participation. At LTPA > median, the life expectancy estimates were 2 years greater compared to 
no LTPA.  For prostate cancer, the life expectancy cancer-free was weaker than the estimates 
observed with other types of cancers. This is most likely due to a null association of LTPA with 
cancer incidence but a strong inverse association with all-cause mortality. In contrast, for 
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colorectal, lung, and breast, LTPA had strong associations with both cancer incidence and all-
cause mortality, and as a result the life expectancy cancer-free was greater for these cancers. 
Our findings are consistent with those of other studies on physical activity and chronic 
disease-free life expectancy. Higher levels of physical activity compared to lower levels or none 
have been associated with a greater CVD-free life expectancy of 3 years,10, 12 greater diabetes-
free life expectancy of 4 years,25 and greater chronic disease-free life expectancy of 3 years.28 
Our work complements these studies by examining four leading cancers types. Additionally, 
specifying LTPA as MET-h/week enhances the translation of our findings. One can reach 6.6 
MET-h/week (midpoint of our lower LTPA category) and 13.7 MET-h/week by taking a brisk 
walk (at 3.3 METs) for 24 and 50 minutes/day for 5 days of the week. 
In our analysis, TV viewing was not associated with any type of cancer. Current research 
suggests no association of TV viewing with breast cancer 8, 86 and prostate cancer 8, 85, mixed 
results for lung cancer,83, 84 and an increased risk of colon cancer with more TV viewing.8, 87, 121 
Our null finding on TV viewing with colorectal cancer may be due to limited power to detect 
differences since we had 361 cases of colorectal cancer in our sample relative to more than 1,000 
cases of colorectal cancer in previous studies on TV viewing.87, 121 We observed that viewing TV 
sometimes or seldom/never was associated with a reduced risk of all-cause mortality, which is 
consistent with existing research.61  
For most cancer states, viewing TV sometimes or seldom/never was associated with ~1 
year gain in cancer-free life expectancy compared to often/very often watching TV. In our 
analysis, TV viewing was not associated with any incident cancers. However, viewing TV 
sometimes or seldom/never was protective against all-cause mortality; this association explains 
the gain in cancer-free life expectancy among those who watched less TV. Although 
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seldom/never viewing TV was associated with a lower risk of all-cause mortality in the prostate 
models, seldom/never viewing TV was associated with an increased risk of prostate cancer. The 
opposing direction for incidence and mortality likely explains why life expectancy prostate-free 
is similar by level of TV watching. We cannot exclude the possibility of residual confounding as 
a possible explanation for the observed increased risk of prostate cancer with less TV viewing.   
Our study has a number of strengths, most importantly we used health expectancy metrics 
to examine how health behaviors influenced years lived cancer-free.18 Additionally, our analyses 
included use of time-varying exposures and covariates to update behaviors as they changed 
throughout the observation period and well-measured and adjudicated outcomes. We addressed 
missing exposure and covariate data with multiple imputation techniques and conducted analysis 
with a prospective population-based cohort with 25 years of follow-up.  
Despite the strengths of our study, limitations should be considered. We did not account 
for physical activity from travel, occupation, and housework and it is possible that the strength of 
observed associations would be greater if activity from multiple domains were included. LTPA 
may be overestimated by self-report, however, the Baecke questionnaire has good reliability and 
validity.116, 117 Our measure of sedentary behavior, TV viewing, does not include time spent 
sitting for work or commuting. Additionally, the TV question assessed frequency of viewing but 
not the number of hours.  
6.5 Conclusion 
Engagement in any LTPA and sometimes or seldom/never viewing TV were associated 
with longer cancer-free life expectancy. Findings were similar for colorectal, lung, and breast 
cancer but weaker for prostate cancer. Our results suggest that engaging in more LTPA and less 
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Table 12. Baseline characteristics of ARIC Study participants, n=14,508. 
  Leisure-time physical activity   TV viewing   Overall  




Sometimes Often/ very 
often 
  
  N=5615 N=4424 N=4446 
 
N=2670 N=6779 N=5030 
 
N=14,508 
Age at V1, mean(SD) 54.4 (5.7) 54.4 (5.8) 54.7 (5.8) 
 
54.0 (5.7) 54.4 (5.7) 54.9 (5.8) 
 
54.3 (5.7) 
Male, % 2312 (41.2) 1801 (40.7) 2454 (55.2) 
 
1098 (41.1) 2905 (42.9) 2562 (50.9) 
 
6582 (45.4) 
ARIC center, n(%) 
         
Forsyth County 1175 (20.9) 1207 (27.3) 1297 (29.2) 
 
705 (26.4) 1759 (26.0) 1213 (24.1) 
 
3682 (25.4) 
Jackson 2119 (37.7) 784 (17.7) 616 (13.9) 
 
400 (15.0) 1634 (24.1) 1485 (29.5) 
 
3536 (24.4) 
Minneapolis 953 (17.0) 1269 (28.7) 1417 (31.9) 
 
845 (31.7) 1644 (24.3) 1150 (22.9) 
 
3640 (25.1) 
Washington County 1368 (24.4) 1164 (26.3) 1116 (25.1) 
 
720 (27.0) 1742 (25.7) 1182 (23.5) 
 
3650 (25.2) 
White, n(%) 3313 (59.0) 3465 (78.3) 3730 (83.9) 
 
2224 (83.3) 4982 (73.5) 3296 (65.5) 
 
10514 (72.5) 
African American, n(%) 2302 (41.0) 959 (21.7) 716 (16.1) 
 




         
high school or less 3771 (67.3) 2383 (53.9) 1984 (44.7) 
 
1292 (48.5) 3747 (55.4) 3094 (61.6) 
 
8155 (56.3) 
vocational 414 (7.4) 405 (9.2) 385 (8.7) 
 
215 (8.1) 566 (8.4) 422 (8.4) 
 
1205 (8.3) 
college 1019 (18.2) 1214 (27.5) 1443 (32.5) 
 
818 (30.7) 1752 (25.9) 1106 (22.0) 
 
3679 (25.4) 
graduate/professional 399 (7.1) 418 (9.5) 627 (14.1) 
 
341 (12.8) 705 (10.4) 398 (7.9) 
 
1445 (10.0) 
Missing 12 4 7 
 





         
no LTPA 
    




    




    




    
0 0 0 
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TV viewing, n(%) 
         
seldom/never 849 (15.1) 805 (18.2) 1016 (22.9) 
     
2670 (18.4) 
sometimes 2603 (46.4) 2042 (46.2) 2134 (48.0) 
     
6779 (46.8) 
often/very often 2161 (38.5) 1575 (35.6) 1294 (29.1) 
     
5030 (34.7) 
Missing 2 2 2 
     
29 
Smoking, n(%) 
         
current smoker 1803 (32.1) 1058 (23.9) 890 (20.0) 
 
543 (20.4) 1650 (24.4) 1557 (31.0) 
 
3760 (25.9) 
past smoker 1510 (26.9) 1409 (31.9) 1739 (39.2) 
 
867 (32.5) 2153 (31.8) 1638 (32.6) 
 
4665 (32.2) 
never smoker 2298 (41.0) 1955 (44.2) 1812 (40.8) 
 
1257 (47.1) 2974 (43.9) 1829 (36.4) 
 
6071 (41.9) 
Missing 4 2 5 
 
3 2 6 
 
12 
Alcohol intake, n(%) 
         
not current drinker 3774 (67.7) 2707 (61.5) 2348 (53.1) 
 
1621 (61.0) 4182 (62.0) 3020 (60.5) 
 
8835 (61.3) 
< 100 grams 1100 (19.7) 1124 (25.5) 1342 (30.4) 
 







  Leisure-time physical activity   TV viewing   Overall  




Sometimes Often/ very 
often 
  
  N=5615 N=4424 N=4446 
 
N=2670 N=6779 N=5030 
 
N=14,508 
> 100 grams 700 (12.6) 574 (13.0) 731 (16.5) 
 
344 (12.9) 887 (13.2) 774 (15.5) 
 
2007 (13.9) 
Missing 41 19 25 
 
11 38 36 
 
100 
BMI, mean (SD) 28.7 (6.0) 27.4 (5.2) 26.9 (4.6) 
 
26.9 (5.0) 27.7 (5.4) 28.3 (5.6) 
 
27.8 (5.4) 
Missing 6 3 2 
 




Therapy, n(%)          
current user of unopposed 
estrogen  
409 (13.1) 335 (13.3) 276 (14.4) 
 
194 (12.8) 512 (13.9) 314 (13.3) 
 
1020 (13.5) 
current user of estrogen + 
progestin 
103 (3.3) 154 (6.1) 165 (8.6) 
 
114 (7.5) 220 (6.0) 88 (3.7) 
 
422 (5.6) 
never used 2194 (70.2) 1650 (65.5) 1175 (61.5)  983 (65.0) 2440 (66.3) 1592 (67.5)  5019 (66.4) 
former user of any type 421 (13.5) 380 (15.1) 296 (15.5)  222 (14.7) 511 (13.9) 364 (15.4)  1097 (14.5) 
Missing 147 80 56  42 158 83  291 
Postmenopausal, n(%) 2948 (90.0) 2303 (88.6) 1730 (87.9)  1322 (85.0) 3427 (89.2) 2228 (91.3)  6988 (89.0) 
Missing 0 0 0  0 0 0  0 
Daily serve red meat intake, 
mean (SD) 
1.2 (1.0) 1.1 (0.8) 1.0 (0.8) 
 
1.0 (0.8) 1.1 (0.8) 1.2 (1.0) 
 
1.1 (0.9) 
Missing 12 4 11   1 16 10   42 
Abbreviations: BMI= body mass index, LTPA= leisure-time moderate-to-vigorous physical activity, MET= metabolic equivalent of task 




Table 13. Associations (hazard ratio, 95% CI) of leisure-time physical activity with 
colorectal, lung, prostate, and breast cancer (disease) and all-cause mortality (death) 
among ARIC Study participants (1987 - 2012).  
  health to disease health to death disease to death 
  HR (95% CI) 
Colorectal 
   
    Number of events 361 4,870 184 
    Total person-years 304,961 304,961 2,618 
LTPA     
    None ref ref ref 
    < median  0.98(0.75,1.29) 0.86(0.80,0.93) 0.85(0.56,1.28) 
    > median  0.81(0.62,1.06) 0.75(0.69,0.80) 1.19(0.82,1.73) 
Lung 
   
    Number of events 560 4,572 482 
    Total person-years 306,286 306,286 1,292.21 
LTPA     
    None ref ref ref 
    < median  0.88(0.70,1.09) 0.87(0.81,0.94) 0.80(0.58,1.10) 
    > median  0.84(0.68,1.04) 0.75(0.70,0.81) 0.93(0.71,1.22) 
Prostate 
   
    Number of events 813 2,475 300 
    Total person-years 127,060 127,060 7,462 
LTPA     
    None ref ref ref 
    < median  1.12(0.92,1.37) 0.90(0.81,1.00) 1.00(0.74,1.37) 
    > median  1.00(0.84,1.19) 0.78(0.70,0.86) 0.86(0.64,1.15) 
Breast 
   
    Number of events 564 2,041 215 
    Total person-years 163,389 163,389 5,401 
LTPA     
    None ref ref ref 
    < median  0.97(0.78,1.19) 0.83(0.74,0.93) 0.65(0.47,0.91) 
    > median  0.84(0.67,1.05) 0.73(0.64,0.83) 0.54(0.37,0.79) 
LTPA categories: < median (0.1 - < 13.2 MET-h/week), > median (13.2+ MET-h/week) 
Colorectal cancer and lung cancer models N=14,508, prostate cancer models N=6582, and breast cancer models 
N=7849 
Models specified separately for each type of cancer. 
Models adjusted for age, gender, race by ARIC center, education, smoking status, and alcohol intake. Prostate and 
breast models do not include gender. 
Abbreviations: HR= hazard ratio, CI = confidence interval, LTPA= leisure-time moderate-to-vigorous physical 






Table 14. Associations (hazard ratio, 95% CI) of TV viewing with colorectal, lung, prostate, 
and breast cancer (disease) and all-cause mortality (death) among ARIC Study 
participants (1987 - 2012). 
  health to disease health to death disease to death 
  HR (95% CI) 
Colorectal 
   
    Number of events 361 4,870 184 
    Total person-years 304,961 304,961 2,618 
TV viewing    
    Often/very often ref ref ref 
    Sometimes 1.05(0.83,1.32) 0.89(0.84,0.95) 0.79(0.57,1.11) 
    Seldom/never 0.96(0.70,1.31) 0.85(0.78,0.93) 0.93(0.59,1.46) 
Lung 
   
    Number of events 560 4,572 482 
    Total person-years 306,286 306,286 1,292.21 
TV viewing    
    Often/very often ref ref ref 
    Sometimes 1.07(0.89,1.29) 0.87(0.82,0.93) 1.09(0.87,1.35) 
    Seldom/never 1.09(0.85,1.40) 0.82(0.75,0.90) 1.32(0.99,1.75) 
Prostate 
   
    Number of events 813 2,475 300 
    Total person-years 127,060 127,060 7,462 
TV viewing    
    Often/very often ref ref ref 
    Sometimes 1.07(0.92,1.25) 0.92(0.85,1.01) 0.85(0.66,1.09) 
    Seldom/never 1.20(0.99,1.47) 0.86(0.76,0.97) 0.96(0.69,1.33) 
Breast 
   
    Number of events 564 2,041 215 
    Total person-years 163,389 163,389 5,401 
TV viewing    
    Often/very often ref ref ref 
    Sometimes 0.95(0.78,1.15) 0.86(0.78,0.94) 0.94(0.69,1.28) 
    Seldom/never 1.03(0.81,1.30) 0.80(0.70,0.92) 1.05(0.71,1.54) 
Colorectal cancer and lung cancer models N=14,508, prostate cancer models N=6582, and breast cancer models 
N=7849 
Models specified separately for each type of cancer. 
Models adjusted for age, gender, race by ARIC center, education, smoking status, and alcohol intake. Prostate and 
breast models do not include gender. 





Figure 9. Life expectancy (years, 95% CI) free of cancer and life expectancy differences at 
age 50 by LTPA among ARIC Study participants (1987 - 2012). 
 
LTPA categories: < median (0.1 - < 13.2 MET-h/week), > median (13.2+ MET-h/week) 
Colorectal cancer and lung cancer models N=14,508, prostate cancer models N=6582, and breast cancer models 
N=7849 
Models specified separately for each type of cancer.  
Models adjusted for age, gender, race by ARIC center, education, smoking status, and alcohol intake. Prostate and 
breast models do not include gender. 
Abbreviations: CI = confidence interval, CRC= colorectal cancer, LE= life expectancy, LTPA=leisure-time 





Figure 10. Life expectancy (years, 95% CI) free of cancer and life expectancy differences at 
age 50 by TV among ARIC Study participants (1987 - 2012). 
 
Colorectal cancer and lung cancer models N=14,508, prostate cancer models N=6582, and breast cancer models 
N=7849 
Models specified separately for each type of cancer.  
Models adjusted for age, gender, race by ARIC center, education, smoking status, and alcohol intake. Prostate and 
breast models do not include gender. 





Figure 11. Life expectancy (years, 95% CI) free of cancer and life expectancy differences at 
age 50 by LTPA and TV viewing among ARIC Study participants (1987 - 2012).  
 
3a) Colorectal cancer 
 















Colorectal cancer and lung cancer models N=14,508, prostate cancer models N=6582, and breast cancer models 
N=7849 
LTPA categories: < median (0.1 - < 13.2 MET-h/week), > median (13.2+ MET-h/week) 
TV categories: high TV is viewing often/very often, some TV is sometimes viewing, and low TV is seldom/never 
viewing TV.  
Models specified separately for each type of cancer.  
Models adjusted for age, gender, race by ARIC center, education, smoking status, and alcohol intake. Prostate and 
breast models do not include gender  
Abbreviations: CI = confidence interval, CRC= colorectal cancer, LE= life expectancy, LTPA=leisure-time 






CHAPTER 7: CONCLUSIONS AND PUBLIC HEALTH IMPLICATIONS 
7.1 Summary of findings 
This doctoral research investigated how physical activity and sedentary behavior are 
associated with life expectancy free of seven leading chronic diseases.  The findings suggest that 
engaging in physical activity and sedentary behavior can influence the number of years lived in 
health.  
The association of physical activity with nonfatal CVD and cancer 
 Participation in LTPA > median in the past year compared to none was associated with a 
reduced risk of three nonfatal CVDs - CHD, stroke, and HF - and three types of cancer - 
colorectal, lung, and breast. LTPA was not associated with prostate cancer.  We observed an 
inverse dose-response relationship between LTPA and all-cause mortality in the absence of 
having each of these diseases in both the CVD and cancer analyses. The association between 
LTPA and all-cause mortality after developing these diseases was less clear. For example, 
engaging in LTPA > median compared to none was associated with a lower risk of all-cause 
mortality after developing nonfatal CHD and HF and postmenopausal breast cancer, but no clear 
pattern was observed for the other diseases.  Our results on the association of physical activity 
with incident CVD and cancer, and with all-cause mortality, are consistent with prior research in 
these areas.  These results suggest that engagement in more LTPA is associated with a lower risk 
of developing various types of CVD and cancer, and a lower risk of all-cause mortality in the 




The association of physical activity with nonfatal CVD- and cancer-free life expectancy 
 LTPA was associated in a positive dose-response fashion with extending life expectancy 
free of nonfatal CVD and three forms of cancer. Compared to no LTPA, participating in LTPA < 
median and > median was associated with a longer nonfatal life expectancy CVD-free by ~1 and 
~2 years, respectively. This was similar for nonfatal CHD, stroke, and HF. The cancer-free life 
expectancies by level of LTPA also showed a very similar dose-response relationship.  
Compared to no LTPA, life expectancy free of colorectal-, lung-, and breast cancer were longer 
by 1 year and more than 2 years for engaging in LTPA < median and > median.  The results were 
weaker for prostate cancer, such that at LTPA levels < median the life expectancy gain was 0.1 
years and at LTPA levels > median the gain was 1.1 years longer compared to no LTPA. The 
weaker results for prostate cancer are most likely due to a null association of LTPA with prostate 
cancer incidence but an inverse association with all-cause mortality. In contrast, for all other 
disease states, LTPA had a strong inverse association with both disease incidence and all-cause 
mortality.  These results suggest that engaging in more LTPA may contribute to more years spent 
free of some of the leading chronic diseases.  
The association of sedentary behavior with nonfatal CVD and cancer 
 Viewing TV seldom/never compared to often/very often was associated with a reduced 
risk of nonfatal CHD and HF; TV viewing was not associated with any of the other diseases. In 
both the CVD and cancer analyses, watching TV sometimes or seldom/never compared to 
often/very often was associated with a lower risk of all-cause mortality in the absence of these 
diseases.  Also consistent with each analysis was a null association of TV viewing with all-cause 




The association of sedentary behavior with nonfatal CVD- and cancer-free life expectancy 
 Viewing TV sometimes or seldom/never was associated with a longer nonfatal CVD- and 
cancer-free life expectancy. For all types of CVD, the nonfatal life expectancy CVD-free was 
greater by ~0.8 years for viewing TV sometimes and seldom/never compared to often/very often 
viewing TV. For the different types of cancer, a similar relationship was observed for colorectal, 
lung, and breast cancer with a longer cancer-free life expectancy ~1 year and ~1.4 years for 
sometimes and seldom/never viewing TV compared to often/very often viewing, respectively. 
These findings suggest viewing less TV may be associated with longer life expectancy free of 
many types of CVD and cancer. 
The one exception was prostate cancer for which the life expectancy prostate cancer-free 
was similar for each level of TV.  Although seldom/never viewing TV was associated with a 
lower risk of all-cause mortality in the prostate models, seldom/never viewing TV was also 
associated with an increased risk of prostate cancer. The opposing direction for incidence and 
mortality likely explains why life expectancy prostate-free is similar by level of TV watching. 
We cannot exclude the possibility of residual confounding as a possible explanation for the 
observed increased risk of prostate cancer with less TV viewing.  
7.2 Strengths 
This dissertation has as number of strengths, which include the examination of seven 
chronic diseases, the inclusion of sedentary behavior, specifying physical activity as MET-
h/week, use of time varying exposures and covariates, and multiple imputation of missing data.   
 To our knowledge, this is the only study to separately examine how physical activity is 
associated with cancer life expectancy outcomes. To date, research in area of physical activity 
with health expectancy outcomes has primarily addressed CVD and composite chronic disease 
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outcomes. The inclusion of cancer is an important innovation as it is one of the leading causes of 
death, premature mortality, and years lived with disability.118 This research highlights how 
engaging in more physical activity and viewing less TV are associated with living more years 
free of four types of cancer.  
We also examined whether sedentary behavior is associated with nonfatal CVD and 
cancer life expectancy outcomes. Many health behaviors and conditions (obesity, smoking, 
alcohol) have been examined with CVD life expectancy outcomes but none have investigated 
sedentary behavior.10, 11 In this analysis we observed that viewing TV sometimes or 
seldom/never was associated with greater life expectancy CVD and cancer-free compared to 
often/very often viewing TV. This is important as sedentary behavior is highly prevalent and 
Americans are sedentary on average 8 hours per day.50 Our results suggest less frequent TV 
watching may extend disease-free life expectancy but future research should use a different 
measure of sedentary behavior if possible, such as hours spent sitting. 
In both the CVD and cancer analysis, we measured physical activity expenditure in MET-
h/week, which enhances the translation of our findings. By using a standardized metric, our 
results can be replicated and compared with other cohorts that use MET-h/week of physical 
activity.  
 As a further strength, in both the CVD and cancer analyses we had extensive follow-up 
time of close to 30 and 25 years, respectively. We accounted for changes in behavior that 
occurred over follow-up by using time-varying exposures and covariates. To address missing 
exposure and covariate data we used multiple imputation techniques, which limited loss to 




 This research is subject to several limitations, one of which is the use of one domain of 
physical activity and sedentary behavior. We included physical activity that occurred during 
leisure-time and did not include physical activity that occurred during work, from doing 
household activities, or while commuting.  The addition of physical activity from these other 
domains may have strengthened the observed associations.  
 Our measure of sedentary behavior was based on a question about TV viewing, which 
omits sedentary behavior that occurs while at work or during travel. Furthermore, this question 
did not able to capture the number of hours spent watching TV, but only the frequency.  
 Both physical activity and TV viewing were self-reported. Physical activity tends to be 
overestimated when self-reported, but the reliability and validity of the Baecke questionnaire is 
similar in reliability and validity as other physical activity questionnaires.116, 117 The questions 
used to ascertain TV viewing from the Baecke questionnaire have not been compared 
specifically against other TV watching measures; however, other validation and reliability 
studies of sedentary questions suggest reliability is high but validity varies for domain-specific 
sedentary behavior (TV viewing, sitting at work).122, 123  For example, in one study both 
reliability and validity (measured as intra-class correlations (ICC)) were moderate to high 
(reliability ICC ranged from 0.65 to 0.86 and validity ICC ranged from 0.53 to 0.77) for both 
sitting at work and watching TV.122   
7.4 Public health significance 
 CVD and cancer are leading chronic diseases; over 92.1 million of living Americans have 
been diagnosed with CVD30 and 15.5 million have a cancer history.32 The results from this 
dissertation suggest that increasing LTPA levels and limiting TV viewing will likely reduce the 
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incidence of some types of CVD and cancer, lower the risk of all-cause mortality, and extend the 
number of years lived free of CVD and cancer. Based on this observational prospective study, it 
is likely that if population physical activity levels increased and sedentary behavior levels 
decreased, fewer people would develop certain types of CVD and cancer and more years of life 
would be spent in health rather than managing morbidity related to these types of conditions. 
Although we lack experimental confirmation of our results, it can be posited that promoting 
physical activity and reducing sedentary behavior have the potential to help millions of 
Americans maintain and improve their health.  
Life expectancy disease-free, the metric used in this dissertation, is easily understood and 
may be an effective motivational tool for behavior change.  Presenting information on the 
number of years one can expect to live healthy, or free of certain chronic diseases, is likely to be 
of interest to many people. In support of this, from interviews with older adults from two US 
aging cohorts, one of the most important priorities mentioned by participants regarding aging 
was to remain in good health until close to death. 124  
This metric targets individual level behavior change. Although individual level behavior 
change is important for increasing physical activity, factors at multiple levels of the environment 
also need to be addressed to have a substantial public health impact on increasing population 
levels of physical activity and decreasing sedentary behavior levels. Several physical activity 
interventions that target community settings, school settings, workplaces, families and the home 
environment, and coordinated environmental interventions have been effective at increasing 
physical activity levels among many population groups.125-129 Conveying the message of how 
physical activity and TV viewing impact the number of years one can expect to live healthy, or 
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free of certain chronic diseases, can be part of a holistic multi-pronged approach to optimize the 
population levels of these behaviors.  
7.5 Future Directions 
 The findings from this dissertation point to several future directions of research. First, 
this type of research should be replicated in other cohorts, especially ones that have a range of 
participants that are diverse in race/ethnicity and socio-economic status.  Many demographic and 
social factors influence disease incidence and mortality risk and it is likely that the magnitude of 
life expectancy estimates will vary between cohorts due to differences in demographic, social 
factors, and risk factor burden.  To further the work on cancer, conducting analysis with 
consortiums would increase the types and number of cancer cases to be investigated.   
Second, additional analyses on physical activity and life expectancy outcomes could 
include activity that occurs in various domains (household, work, leisure-time, commuting). It 
would also be advantageous for future research to include regular assessments of physical 
activity to update changes in physical activity participation throughout the observation period. 
Additionally, accelerometers could be used to examine how objective measures of physical 
activity are associated with disease-free life expectancy. This type of analysis could, in addition 
to examining moderate-to-vigorous intensity physical activity, also investigate how light 
intensity and number of steps are associated with disease-free life expectancy outcomes. Limited 
research suggests that number of steps may be inversely associated with incident CVD.130 
Additionally, greater amounts of light intensity activity may be associated with lower CVD 
risk.131 Similar to physical activity, other measures of sedentary behavior should be used in 
future research on disease-free life expectancy outcomes. Self-reported measures of total sitting 
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time or accelerometer measured sedentary time could be further informative in addition to our 
single measure of TV viewing frequency. 
 Third, in this dissertation we focused on two modifiable behaviors, but research suggests 
that engaging in multiple health behaviors has been associated with longer life expectancy,132 a 
lower risk of CVD,133 a reduced risk of cancer,134, 135 and longer CVD-free life expectancy.10, 11 
For example, in one study on CVD-free life expectancy, participants with a favorable risk profile 
based on smoking, physical activity, BMI, and alcohol intake had a longer CVD-free life 
expectancy of 8 to 13 years compared to participants with an unfavorable risk profile.10  This 
dissertation research thus could be extended to include multiple health behaviors or use the 
American Heart Association’s Life Simple 7 metric (smoking, body mass index, physical 
activity, diet, total cholesterol, blood glucose, blood pressure) to examine how each individual 
behavior and a combined number of health behaviors influence life expectancy free of CVD and 
cancer.    
Fourth, health expectancy outcomes can be used to monitor trends in life expectancy in 
good and poor health over time. The European Union (EU) has used three types of life 
expectancy measures based on questions about activity limitations, chronic morbidity, and 
perceived health to monitor trends since 2004 in 28 EU member states.136 In the US, the Centers 
for Disease Control and Prevention (CDC) published life expectancy at age 65 in good and poor 
self-rated health.137 The CDC used data from the National Vital Statistics System, the Census 
Bureau, and the Behavioral Risk Factor Surveillance Study. These data inputs were used with 
modified life tables to partition life expectancy into good and poor self-rated health.137 It may be 
possible to extend these types of analyses into life expectancy with and without disease based on 
current mortality data and self-reported diseases (such as CVD and cancer) with the use of 
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nationally representative studies, such as NHANES or the National Health Interview Survey.  In 
these types of analyses, life expectancy with and without disease could be examined over time 
and by demographic factors to monitor population health.138   
7.6 Conclusions 
 Engagement in any LTPA compared to none was associated with a longer disease-free 
life expectancy for all CVDs and cancer types. For example, engaging in LTPA greater than or 
equal to the median compared to no LTPA was associated with a longer disease-free life 
expectancy of ~1.5 years for CHD, ~1.8 years for stroke, ~1.6 years for HF, ~2.2 years for 
colorectal, ~2.1 years for lung, ~1.5 years for prostate, and ~2.4 years for postmenopausal breast 
cancer. Viewing TV sometimes or seldom/never compared to often/very often viewing was 
associated with longer CVD and cancer-free life expectancy of ~1 year for all diseases except for 
prostate cancer. In comparison to LTPA, the life expectancy differences by level of TV were 
more modest than the differences by level of LTPA. Our results suggest that engaging in more 
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